| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.745 | 0.007 | 0.745 | Streptokinase A inhibitor | 0.317 0.072 CID_14535 | ||
| 0.618 | 0.004 | 0.721 | Peroxidase inhibitor | 0.655 0.004 CID_6115 0.721 0.003 CID_14535 | CID_14535 | |
| 0.6 | 0.013 | 0.6 | 12-Lipoxygenase inhibitor | 0.272 0.096 CID_6115 0.457 0.027 CID_14535 | ||
| 0.608 | 0.023 | 0.608 | 15-Lipoxygenase inhibitor | 0.373 0.086 CID_6115 0.424 0.064 CID_14535 | ||
| 0.57 | 0.009 | 0.57 | Amyloid beta aggregation inhibitor | 0.172 0.094 CID_6115 0.357 0.033 CID_14535 | ||
| 0.57 | 0.023 | 0.735 | Aldehyde oxidase inhibitor | 0.623 0.016 CID_6115 0.735 0.006 CID_14535 | CID_14535 | |
| 0.547 | 0.015 | 0.679 | GABA C receptor rho-3 antagonist | 0.679 0.004 CID_6115 0.653 0.004 CID_14535 | CID_6115 | |
| 0.515 | 0.018 | 0.515 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.408 0.036 CID_6115 0.459 0.026 CID_14535 | ||
| 0.504 | 0.012 | 0.504 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.337 0.038 CID_6115 0.357 0.034 CID_14535 | ||
| 0.498 | 0.013 | 0.532 | Superoxide dismutase inhibitor | 0.482 0.015 CID_6115 0.532 0.01 CID_14535 | CID_14535 | |
| 0.495 | 0.015 | 0.495 | Hypoxia-inducible factor 1 alpha inhibitor | 0.24 0.11 CID_6115 0.399 0.03 CID_14535 | ||
| 0.475 | 0.011 | 0.475 | Pyruvate kinase inhibitor | 0.234 0.066 CID_6115 0.36 0.031 CID_14535 | ||
| 0.469 | 0.017 | 0.469 | Dyrk kinase inhibitor | 0.348 0.038 CID_6115 0.339 0.04 CID_14535 | ||
| 0.44 | 0.005 | 0.44 | Heat shock protein 90 alpha antagonist | 0.196 0.052 CID_6115 0.39 0.005 CID_14535 | ||
| 0.456 | 0.047 | 0.565 | Histamine release inhibitor | 0.465 0.043 CID_6115 0.565 0.014 CID_14535 | CID_14535 | |
| 0.452 | 0.051 | 0.509 | 5 Hydroxytryptamine release inhibitor | 0.509 0.029 CID_6115 0.448 0.052 CID_14535 | CID_6115 | |
| 0.412 | 0.014 | 0.412 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 CID_14535 | ||
| 0.475 | 0.083 | 0.475 | Transcription factor inhibitor | 0.239 0.194 CID_6115 | ||
| 0.417 | 0.046 | 0.417 | Cholesterol antagonist | 0.344 0.067 CID_6115 0.326 0.076 CID_14535 | ||
| 0.373 | 0.005 | 0.373 | Heat shock protein 90 antagonist | 0.176 0.051 CID_6115 0.35 0.005 CID_14535 | ||
| 0.436 | 0.071 | 0.543 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.543 0.018 CID_6115 0.429 0.076 CID_14535 | CID_6115 | |
| 0.425 | 0.06 | 0.425 | Prostaglandin dehydrogenase inhibitor | 0.276 0.114 CID_6115 0.415 0.063 CID_14535 | ||
| 0.365 | 0.013 | 0.408 | Tyrosine 3 hydroxylase inhibitor | 0.392 0.009 CID_6115 0.408 0.007 CID_14535 | CID_14535 | |
| 0.357 | 0.007 | 0.357 | M18 aspartyl aminopeptidase inhibitor | 0.252 0.02 CID_14535 | ||
| 0.38 | 0.033 | 0.38 | Free radical scavenger | 0.265 0.062 CID_14535 | ||
| 0.444 | 0.103 | 0.444 | DNA polymerase beta inhibitor | 0.244 0.196 CID_6115 | ||
| 0.353 | 0.014 | 0.353 | Monophenol monooxygenase inhibitor | 0.137 0.052 CID_6115 0.204 0.032 CID_14535 | ||
| 0.339 | 0.003 | 0.339 | HIV-1 integrase (Overall Integration) inhibitor | 0.286 0.004 CID_6115 0.296 0.004 CID_14535 | ||
| 0.373 | 0.04 | 0.373 | Antioxidant | 0.277 0.071 CID_14535 | ||
| 0.348 | 0.016 | 0.353 | Mcl-1 antagonist | 0.353 0.015 CID_14535 | CID_14535 | |
| 0.434 | 0.103 | 0.434 | DNA directed DNA polymerase inhibitor | 0.252 0.19 CID_6115 | ||
| 0.423 | 0.092 | 0.423 | MAP kinase 1 inhibitor | 0.289 0.193 CID_6115 0.278 0.204 CID_14535 | ||
| 0.365 | 0.046 | 0.365 | Lipoxygenase inhibitor | 0.2 0.14 CID_6115 0.346 0.052 CID_14535 | ||
| 0.333 | 0.015 | 0.361 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.359 0.011 CID_6115 0.361 0.011 CID_14535 | CID_14535 | |
| 0.322 | 0.005 | 0.322 | Catenin beta inhibitor | 0.245 0.012 CID_6115 0.189 0.042 CID_14535 | ||
| 0.347 | 0.035 | 0.347 | Transcription factor STAT inhibitor | 0.212 0.122 CID_6115 0.269 0.075 CID_14535 | ||
| 0.374 | 0.07 | 0.374 | Transcription factor NF kappa B inhibitor | 0.31 0.089 CID_6115 0.337 0.081 CID_14535 | ||
| 0.409 | 0.105 | 0.452 | Caspase 9 stimulant | 0.452 0.082 CID_6115 0.422 0.098 CID_14535 | CID_6115 | |
| 0.331 | 0.039 | 0.331 | Transcription factor STAT3 inhibitor | 0.205 0.127 CID_6115 0.263 0.074 CID_14535 | ||
| 0.377 | 0.088 | 0.382 | Antibacterial | 0.335 0.111 CID_6115 0.382 0.085 CID_14535 | CID_14535 | |
| 0.292 | 0.005 | 0.292 | HIV-1 integrase (3'-Processing) inhibitor | 0.105 0.024 CID_14535 | ||
| 0.36 | 0.073 | 0.36 | Thioredoxin glutathione reductase inhibitor | |||
| 0.391 | 0.118 | 0.41 | Apoptosis agonist | 0.41 0.109 CID_14535 | CID_14535 | |
| 0.275 | 0.007 | 0.275 | Carbonic anhydrase III inhibitor | 0.266 0.008 CID_6115 0.266 0.008 CID_14535 | ||
| 0.308 | 0.041 | 0.42 | 5 Hydroxytryptamine uptake stimulant | 0.42 0.011 CID_6115 0.388 0.017 CID_14535 | CID_6115 | |
| 0.262 | 0.005 | 0.262 | HIV-1 integrase (Strand Transfer) inhibitor | 0.075 0.033 CID_14535 | ||
| 0.268 | 0.017 | 0.297 | Succinate dehydrogenase inhibitor | 0.297 0.011 CID_6115 0.269 0.017 CID_14535 | CID_6115 | |
| 0.254 | 0.005 | 0.282 | Potassium channel large-conductance Ca-activated activator | 0.084 0.032 CID_6115 0.282 0.005 CID_14535 | CID_14535 | |
| 0.264 | 0.015 | 0.264 | Hexokinase inhibitor | 0.252 0.017 CID_6115 0.263 0.015 CID_14535 | ||
| 0.3 | 0.052 | 0.3 | Antiamyloidogenic | 0.213 0.091 CID_6115 0.239 0.076 CID_14535 | ||
| 0.248 | 0.005 | 0.248 | Creatine kinase inhibitor | 0.208 0.009 CID_6115 0.248 0.005 CID_14535 | ||
| 0.26 | 0.019 | 0.26 | M17 leucyl aminopeptidase inhibitor | 0.126 0.073 CID_6115 | ||
| 0.254 | 0.015 | 0.32 | Cystathionine beta-synthase inhibitor | 0.251 0.015 CID_6115 0.32 0.008 CID_14535 | CID_14535 | |
| 0.36 | 0.131 | 0.393 | Alpha-glucosidase inhibitor | 0.243 0.192 CID_6115 0.393 0.118 CID_14535 | CID_14535 | |
| 0.238 | 0.009 | 0.277 | Potassium channel (Ca-activated) activator | 0.188 0.017 CID_6115 0.277 0.006 CID_14535 | CID_14535 | |
| 0.293 | 0.072 | 0.609 | 5 Hydroxytryptamine release stimulant | 0.609 0.014 CID_6115 0.511 0.025 CID_14535 | CID_6115 | |
| 0.285 | 0.063 | 0.306 | DNA damaging | 0.306 0.055 CID_6115 0.242 0.085 CID_14535 | CID_6115 | |
| 0.342 | 0.123 | 0.531 | Calcium channel L-type activator | 0.531 0.018 CID_6115 0.518 0.022 CID_14535 | CID_6115 | |
| 0.231 | 0.016 | 0.321 | Interleukin 4 antagonist | 0.321 0.007 CID_14535 | CID_14535 | |
| 0.224 | 0.009 | 0.365 | GABA C receptor antagonist | 0.365 0.004 CID_6115 0.258 0.006 CID_14535 | CID_6115 | |
| 0.223 | 0.01 | 0.264 | Porphobilinogen synthase inhibitor | 0.264 0.007 CID_6115 0.256 0.007 CID_14535 | CID_6115 | |
| 0.224 | 0.019 | 0.25 | Mannose-6-phosphate isomerase inhibitor | 0.25 0.012 CID_6115 0.241 0.014 CID_14535 | CID_6115 | |
| 0.25 | 0.047 | 0.25 | DNA methyltransferase I inhibitor | 0.234 0.054 CID_6115 0.225 0.058 CID_14535 | ||
| 0.238 | 0.041 | 0.238 | Dual specificity phosphatase inhibitor | 0.15 0.094 CID_14535 | ||
| 0.241 | 0.044 | 0.321 | Neurotrophic factor enhancer | 0.321 0.013 CID_6115 0.311 0.015 CID_14535 | CID_6115 | |
| 0.223 | 0.028 | 0.422 | Alpha-N-acetylglucosaminidase inhibitor | 0.422 0.008 CID_6115 0.255 0.022 CID_14535 | CID_6115 | |
| 0.25 | 0.066 | 0.345 | DNA synthesis inhibitor | 0.345 0.031 CID_6115 0.258 0.061 CID_14535 | CID_6115 | |
| 0.191 | 0.009 | 0.191 | Macrophage migration inhibitory factor inhibitor | 0.075 0.058 CID_6115 0.127 0.023 CID_14535 | ||
| 0.237 | 0.056 | 0.479 | Anesthetic general | 0.479 0.009 CID_6115 0.372 0.02 CID_14535 | CID_6115 | |
| 0.199 | 0.019 | 0.364 | Carbonic anhydrase XV inhibitor | 0.364 0.005 CID_6115 0.338 0.005 CID_14535 | CID_6115 | |
| 0.202 | 0.027 | 0.346 | GABA C receptor rho-2 antagonist | 0.346 0.004 CID_6115 0.285 0.007 CID_14535 | CID_6115 | |
| 0.195 | 0.021 | 0.538 | GABA C receptor agonist | 0.538 0.003 CID_6115 0.371 0.006 CID_14535 | CID_6115 | |
| 0.259 | 0.088 | 0.321 | Insulysin inhibitor | 0.321 0.047 CID_6115 0.311 0.052 CID_14535 | CID_6115 | |
| 0.176 | 0.007 | 0.176 | Purinergic P2X2 antagonist | 0.118 0.022 CID_6115 0.105 0.027 CID_14535 | ||
| 0.224 | 0.055 | 0.313 | Nitric-oxide synthase stimulant | 0.313 0.009 CID_6115 0.262 0.025 CID_14535 | CID_6115 | |
| 0.19 | 0.022 | 0.19 | Xanthine oxidase inhibitor | 0.086 0.078 CID_6115 0.129 0.043 CID_14535 | ||
| 0.222 | 0.054 | 0.286 | I kappa B kinase epsilon inhibitor | 0.286 0.02 CID_6115 0.229 0.049 CID_14535 | CID_6115 | |
| 0.215 | 0.053 | 0.215 | Dual specificity phosphatase 3 inhibitor | 0.17 0.08 CID_14535 | ||
| 0.19 | 0.03 | 0.266 | Aldehyde dehydrogenase inhibitor | 0.185 0.032 CID_6115 0.266 0.015 CID_14535 | CID_14535 | |
| 0.164 | 0.005 | 0.169 | Purinergic P2X1 antagonist | 0.169 0.005 CID_6115 0.139 0.008 CID_14535 | CID_6115 | |
| 0.276 | 0.117 | 0.419 | Calcium channel activator | 0.419 0.019 CID_6115 0.361 0.043 CID_14535 | CID_6115 | |
| 0.196 | 0.037 | 0.213 | Arachidonic acid antagonist | 0.213 0.022 CID_6115 0.208 0.026 CID_14535 | CID_6115 | |
| 0.221 | 0.066 | 0.231 | DNA methylase inhibitor | 0.231 0.06 CID_6115 0.213 0.071 CID_14535 | CID_6115 | |
| 0.171 | 0.017 | 0.174 | DNA repair enzyme inhibitor | 0.174 0.016 CID_6115 0.171 0.017 CID_14535 | CID_6115 | |
| 0.161 | 0.009 | 0.345 | Alcohol oxidase inhibitor | 0.345 0.004 CID_6115 0.237 0.005 CID_14535 | CID_6115 | |
| 0.173 | 0.023 | 0.269 | UDP-glucose 4-epimerase inhibitor | 0.269 0.012 CID_6115 0.194 0.019 CID_14535 | CID_6115 | |
| 0.178 | 0.027 | 0.178 | Histone deacetylase class III inhibitor | |||
| 0.183 | 0.034 | 0.221 | CF transmembrane conductance regulator agonist | 0.22 0.013 CID_6115 0.221 0.013 CID_14535 | CID_14535 | |
| 0.237 | 0.089 | 0.299 | 5 Hydroxytryptamine 1E antagonist | 0.299 0.03 CID_6115 0.281 0.044 CID_14535 | CID_6115 | |
| 0.175 | 0.029 | 0.388 | Ferrochelatase inhibitor | 0.388 0.004 CID_6115 0.185 0.026 CID_14535 | CID_6115 | |
| 0.203 | 0.058 | 0.279 | 5 Hydroxytryptamine 3E antagonist | 0.279 0.008 CID_6115 0.226 0.031 CID_14535 | CID_6115 | |
| 0.159 | 0.016 | 0.209 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.147 0.019 CID_6115 0.209 0.009 CID_14535 | CID_14535 | |
| 0.165 | 0.022 | 0.165 | TRPA1 agonist | 0.124 0.053 CID_6115 0.113 0.067 CID_14535 | ||
| 0.158 | 0.017 | 0.206 | DOPA decarboxylase inhibitor | 0.176 0.011 CID_6115 0.206 0.006 CID_14535 | CID_14535 | |
| 0.152 | 0.011 | 0.303 | Phenylalanine 4-hydroxylase inhibitor | 0.214 0.006 CID_6115 0.303 0.004 CID_14535 | CID_14535 | |
| 0.188 | 0.048 | 0.188 | ATPase inhibitor | 0.185 0.052 CID_6115 0.167 0.075 CID_14535 | ||
| 0.145 | 0.006 | 0.192 | D-Ala-D-Ala ligase inhibitor | 0.183 0.004 CID_6115 0.192 0.004 CID_14535 | CID_14535 | |
| 0.227 | 0.089 | 0.472 | Aryl hydrocarbon receptor agonist | 0.472 0.027 CID_6115 0.367 0.044 CID_14535 | CID_6115 | |
| 0.178 | 0.041 | 0.178 | Histone deacetylase SIRT1 inhibitor | 0.125 0.085 CID_6115 | ||
| 0.169 | 0.033 | 0.169 | Protein kinase (CK2) alpha inhibitor | 0.135 0.051 CID_6115 0.111 0.068 CID_14535 | ||
| 0.164 | 0.028 | 0.164 | Protein kinase (CK2) inhibitor | 0.118 0.05 CID_6115 0.102 0.062 CID_14535 | ||
| 0.16 | 0.024 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 CID_6115 0.168 0.015 CID_14535 | CID_6115 | |
| 0.158 | 0.023 | 0.158 | Caspase 3 inhibitor | 0.102 0.089 CID_6115 0.122 0.058 CID_14535 | ||
| 0.177 | 0.044 | 0.177 | Alkaline phosphatase inhibitor | 0.163 0.052 CID_6115 0.164 0.051 CID_14535 | ||
| 0.16 | 0.03 | 0.263 | 5 Hydroxytryptamine 3A agonist | 0.263 0.005 CID_6115 0.199 0.015 CID_14535 | CID_6115 | |
| 0.182 | 0.055 | 0.182 | Protein-tyrosine phosphatase inhibitor | 0.139 0.091 CID_14535 | ||
| 0.206 | 0.08 | 0.306 | Interleukin antagonist | 0.144 0.122 CID_6115 0.306 0.046 CID_14535 | CID_14535 | |
| 0.167 | 0.042 | 0.167 | Topoisomerase II inhibitor | 0.094 0.092 CID_6115 0.135 0.057 CID_14535 | ||
| 0.147 | 0.026 | 0.147 | CC chemokine 6 receptor antagonist | 0.144 0.032 CID_14535 | ||
| 0.181 | 0.06 | 0.368 | Phospholipase C inhibitor | 0.368 0.013 CID_6115 0.289 0.019 CID_14535 | CID_6115 | |
| 0.195 | 0.074 | 0.261 | Focal adhesion kinase 2 inhibitor | 0.261 0.032 CID_6115 0.17 0.1 CID_14535 | CID_6115 | |
| 0.138 | 0.018 | 0.138 | Carbonic anhydrase inhibitor | 0.092 0.03 CID_6115 | ||
| 0.171 | 0.052 | 0.229 | Ribosomal protein S6 kinase inhibitor | 0.229 0.027 CID_6115 0.184 0.044 CID_14535 | CID_6115 | |
| 0.131 | 0.012 | 0.131 | HIV-1 integrase inhibitor | |||
| 0.128 | 0.01 | 0.128 | Neuraminidase (influenza) inhibitor | |||
| 0.161 | 0.045 | 0.174 | Toll-Like receptor 2 antagonist | 0.147 0.055 CID_6115 0.174 0.037 CID_14535 | CID_14535 | |
| 0.206 | 0.09 | 0.378 | RNA-directed DNA polymerase inhibitor | 0.378 0.02 CID_6115 0.295 0.033 CID_14535 | CID_6115 | |
| 0.121 | 0.005 | 0.143 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.143 0.004 CID_6115 0.122 0.005 CID_14535 | CID_6115 | |
| 0.16 | 0.045 | 0.253 | Anesthetic local | 0.253 0.019 CID_6115 0.166 0.042 CID_14535 | CID_6115 | |
| 0.162 | 0.048 | 0.253 | NADPH oxidase inhibitor | 0.237 0.024 CID_6115 0.253 0.02 CID_14535 | CID_14535 | |
| 0.136 | 0.022 | 0.271 | NADH dehydrogenase inhibitor | 0.271 0.007 CID_6115 0.19 0.011 CID_14535 | CID_6115 | |
| 0.138 | 0.024 | 0.237 | Triose-phosphate isomerase inhibitor | 0.237 0.008 CID_6115 0.146 0.021 CID_14535 | CID_6115 | |
| 0.172 | 0.061 | 0.2 | Cytidine deaminase inhibitor | 0.2 0.048 CID_6115 | CID_6115 | |
| 0.166 | 0.057 | 0.266 | Amylase inhibitor | 0.266 0.024 CID_6115 0.227 0.035 CID_14535 | CID_6115 | |
| 0.123 | 0.014 | 0.123 | Histone deacetylase SIRT2 inhibitor | |||
| 0.158 | 0.05 | 0.217 | Adenylate cyclase stimulant | 0.217 0.008 CID_6115 0.196 0.015 CID_14535 | CID_6115 | |
| 0.133 | 0.027 | 0.193 | Alcohol dehydrogenase inhibitor | 0.139 0.024 CID_6115 0.193 0.013 CID_14535 | CID_14535 | |
| 0.156 | 0.051 | 0.156 | MAP3K9 inhibitor | |||
| 0.189 | 0.085 | 0.205 | Insulin sensitizer | 0.205 0.069 CID_6115 0.181 0.094 CID_14535 | CID_6115 | |
| 0.12 | 0.016 | 0.168 | Granulocyte macrophage colony stimulating factor agonist | 0.166 0.004 CID_6115 0.168 0.004 CID_14535 | CID_14535 | |
| 0.137 | 0.036 | 0.148 | Transcription factor STAT6 inhibitor | 0.148 0.025 CID_6115 0.118 0.063 CID_14535 | CID_6115 | |
| 0.127 | 0.026 | 0.129 | Estrogen receptor beta antagonist | 0.129 0.024 CID_14535 | CID_14535 | |
| 0.129 | 0.031 | 0.143 | Anabolic | 0.143 0.022 CID_6115 0.127 0.033 CID_14535 | CID_6115 | |
| 0.129 | 0.033 | 0.312 | GABA C receptor rho-1 antagonist | 0.312 0.003 CID_6115 0.228 0.005 CID_14535 | CID_6115 | |
| 0.115 | 0.018 | 0.25 | GABA aminotransferase inhibitor | 0.25 0.004 CID_6115 0.178 0.005 CID_14535 | CID_6115 | |
| 0.132 | 0.036 | 0.134 | Estrogen antagonist | 0.134 0.033 CID_14535 | CID_14535 | |
| 0.162 | 0.067 | 0.168 | Melanin inhibitor | 0.145 0.088 CID_6115 0.168 0.061 CID_14535 | CID_14535 | |
| 0.111 | 0.016 | 0.111 | Carbonic anhydrase II inhibitor | 0.08 0.025 CID_6115 | ||
| 0.11 | 0.015 | 0.125 | Estrogen-related receptor beta agonist | 0.12 0.01 CID_6115 0.125 0.008 CID_14535 | CID_14535 | |
| 0.144 | 0.051 | 0.233 | Cathepsin H inhibitor | 0.233 0.016 CID_6115 0.166 0.036 CID_14535 | CID_6115 | |
| 0.127 | 0.035 | 0.235 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.235 0.011 CID_6115 0.156 0.025 CID_14535 | CID_6115 | |
| 0.095 | 0.004 | 0.095 | Alpha 1d adrenoreceptor agonist | 0.089 0.004 CID_6115 0.087 0.004 CID_14535 | ||
| 0.128 | 0.037 | 0.288 | Adenylate kinase inhibitor | 0.288 0.008 CID_6115 0.181 0.018 CID_14535 | CID_6115 | |
| 0.116 | 0.025 | 0.241 | Glutamate release inhibitor | 0.241 0.004 CID_6115 0.19 0.005 CID_14535 | CID_6115 | |
| 0.163 | 0.073 | 0.188 | Neurotensin receptor agonist | 0.188 0.042 CID_6115 0.182 0.047 CID_14535 | CID_6115 | |
| 0.12 | 0.029 | 0.265 | Carbonic anhydrase VI inhibitor | 0.265 0.008 CID_6115 0.226 0.01 CID_14535 | CID_6115 | |
| 0.125 | 0.036 | 0.125 | Breast cancer-resistant protein inhibitor | 0.086 0.071 CID_6115 0.107 0.049 CID_14535 | ||
| 0.148 | 0.061 | 0.148 | MAO inhibitor | 0.123 0.073 CID_6115 0.121 0.074 CID_14535 | ||
| 0.105 | 0.017 | 0.105 | Carbonic anhydrase I inhibitor | 0.08 0.025 CID_6115 | ||
| 0.119 | 0.033 | 0.119 | Potassium channel activator | 0.115 0.035 CID_6115 0.093 0.056 CID_14535 | ||
| 0.111 | 0.025 | 0.123 | Keratolytic | 0.103 0.029 CID_6115 0.123 0.02 CID_14535 | CID_14535 | |
| 0.091 | 0.005 | 0.091 | Purinergic P2X4 antagonist | 0.052 0.022 CID_6115 0.055 0.019 CID_14535 | ||
| 0.101 | 0.015 | 0.101 | Xanthine dehydrogenase inhibitor | 0.078 0.026 CID_14535 | ||
| 0.152 | 0.067 | 0.154 | Thiol protease inhibitor | 0.154 0.065 CID_6115 0.133 0.091 CID_14535 | CID_6115 | |
| 0.11 | 0.025 | 0.156 | Glutamate decarboxylase inhibitor | 0.156 0.012 CID_6115 0.141 0.015 CID_14535 | CID_6115 | |
| 0.121 | 0.037 | 0.145 | Prolactin inhibitor | 0.145 0.024 CID_6115 0.144 0.025 CID_14535 | CID_6115 | |
| 0.093 | 0.01 | 0.093 | Glucosylceramidase inhibitor | 0.06 0.031 CID_6115 0.072 0.021 CID_14535 | ||
| 0.179 | 0.096 | 0.377 | MAP kinase kinase 2 inhibitor | 0.369 0.017 CID_6115 0.377 0.015 CID_14535 | CID_14535 | |
| 0.129 | 0.046 | 0.129 | MAO B inhibitor | 0.083 0.073 CID_6115 0.088 0.068 CID_14535 | ||
| 0.112 | 0.03 | 0.134 | Interleukin 5 antagonist | 0.134 0.016 CID_14535 | CID_14535 | |
| 0.092 | 0.012 | 0.092 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 CID_6115 0.085 0.014 CID_14535 | ||
| 0.15 | 0.07 | 0.15 | Cyclooxygenase inhibitor | 0.118 0.102 CID_14535 | ||
| 0.135 | 0.055 | 0.179 | Alkylator | 0.179 0.033 CID_6115 0.125 0.063 CID_14535 | CID_6115 | |
| 0.226 | 0.147 | 0.28 | Antithrombotic | 0.229 0.145 CID_6115 0.28 0.103 CID_14535 | CID_14535 | |
| 0.096 | 0.018 | 0.113 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.087 0.021 CID_6115 0.113 0.013 CID_14535 | CID_14535 | |
| 0.184 | 0.107 | 0.293 | Cyclic AMP phosphodiesterase inhibitor | 0.293 0.045 CID_6115 0.241 0.068 CID_14535 | CID_6115 | |
| 0.093 | 0.018 | 0.183 | Carbonic anhydrase VB inhibitor | 0.183 0.006 CID_6115 0.123 0.012 CID_14535 | CID_6115 | |
| 0.104 | 0.03 | 0.181 | Myeloperoxidase inhibitor | 0.181 0.007 CID_6115 0.121 0.019 CID_14535 | CID_6115 | |
| 0.089 | 0.015 | 0.158 | Heat shock protein 90 beta antagonist | 0.102 0.01 CID_6115 0.158 0.004 CID_14535 | CID_14535 | |
| 0.109 | 0.035 | 0.109 | Ornithine decarboxylase inhibitor | 0.102 0.042 CID_6115 0.102 0.042 CID_14535 | ||
| 0.145 | 0.072 | 0.19 | Protein kinase stimulant | 0.188 0.046 CID_6115 0.19 0.045 CID_14535 | CID_14535 | |
| 0.126 | 0.054 | 0.2 | Interleukin 8 antagonist | 0.2 0.013 CID_6115 0.19 0.015 CID_14535 | CID_6115 | |
| 0.155 | 0.082 | 0.519 | Sigma receptor agonist | 0.519 0.008 CID_6115 0.359 0.029 CID_14535 | CID_6115 | |
| 0.094 | 0.021 | 0.117 | GABA B receptor agonist | 0.117 0.008 CID_6115 0.112 0.01 CID_14535 | CID_6115 | |
| 0.088 | 0.017 | 0.12 | NMDA 2A receptor antagonist | 0.12 0.009 CID_6115 0.112 0.011 CID_14535 | CID_6115 | |
| 0.102 | 0.031 | 0.337 | Histidine decarboxylase inhibitor | 0.258 0.008 CID_6115 0.337 0.005 CID_14535 | CID_14535 | |
| 0.098 | 0.028 | 0.098 | Estrogen receptor alpha antagonist | 0.095 0.031 CID_14535 | ||
| 0.076 | 0.007 | 0.125 | Dopamine D5 agonist | 0.095 0.004 CID_6115 0.125 0.003 CID_14535 | CID_14535 | |
| 0.09 | 0.022 | 0.09 | Carbonic anhydrase XII inhibitor | 0.075 0.027 CID_6115 0.045 0.042 CID_14535 | ||
| 0.087 | 0.02 | 0.118 | Glutamate (mGluR7) antagonist | 0.118 0.005 CID_6115 0.096 0.013 CID_14535 | CID_6115 | |
| 0.122 | 0.055 | 0.166 | Photosensitizer | 0.166 0.023 CID_6115 0.153 0.029 CID_14535 | CID_6115 | |
| 0.148 | 0.081 | 0.179 | Interferon gamma antagonist | 0.179 0.051 CID_6115 0.162 0.064 CID_14535 | CID_6115 | |
| 0.142 | 0.075 | 0.174 | Sphingosine 1-phosphate receptor 5 antagonist | 0.174 0.03 CID_6115 0.154 0.054 CID_14535 | CID_6115 | |
| 0.187 | 0.121 | 0.359 | MAP-kinase-activated kinase 5 inhibitor | 0.267 0.049 CID_6115 0.359 0.009 CID_14535 | CID_14535 | |
| 0.083 | 0.017 | 0.083 | Autotaxin inhibitor | |||
| 0.127 | 0.062 | 0.194 | Adenylate cyclase inhibitor | 0.194 0.027 CID_6115 0.187 0.028 CID_14535 | CID_6115 | |
| 0.09 | 0.025 | 0.111 | MAP kinase kinase 7 inhibitor | 0.109 0.007 CID_6115 0.111 0.006 CID_14535 | CID_14535 | |
| 0.118 | 0.055 | 0.189 | Falcipain 3 inhibitor | 0.189 0.021 CID_6115 0.14 0.042 CID_14535 | CID_6115 | |
| 0.086 | 0.023 | 0.099 | CDC25B inhibitor | 0.099 0.016 CID_14535 | CID_14535 | |
| 0.117 | 0.054 | 0.117 | MAO A inhibitor | 0.116 0.054 CID_6115 0.113 0.056 CID_14535 | ||
| 0.085 | 0.022 | 0.085 | Aryl hydrocarbon receptor antagonist | 0.072 0.035 CID_6115 | ||
| 0.1 | 0.037 | 0.144 | Adrenaline agonist | 0.096 0.04 CID_6115 0.144 0.016 CID_14535 | CID_14535 | |
| 0.093 | 0.031 | 0.101 | CC chemokine 5 receptor agonist | 0.101 0.02 CID_6115 0.087 0.043 CID_14535 | CID_6115 | |
| 0.125 | 0.064 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 CID_6115 0.13 0.056 CID_14535 | CID_6115 | |
| 0.095 | 0.034 | 0.189 | Phosphofructokinase-1 inhibitor | 0.189 0.012 CID_6115 0.139 0.02 CID_14535 | CID_6115 | |
| 0.09 | 0.03 | 0.151 | Carbonic anhydrase VA inhibitor | 0.151 0.01 CID_6115 0.104 0.023 CID_14535 | CID_6115 | |
| 0.187 | 0.126 | 0.212 | Calpain inhibitor | 0.212 0.102 CID_6115 0.165 0.156 CID_14535 | CID_6115 | |
| 0.072 | 0.012 | 0.072 | CXC chemokine 1 receptor antagonist | 0.072 0.011 CID_14535 | ||
| 0.13 | 0.07 | 0.13 | Cyclooxygenase 2 inhibitor | |||
| 0.193 | 0.133 | 0.266 | Neuropeptide Y2 antagonist | 0.266 0.042 CID_6115 0.212 0.099 CID_14535 | CID_6115 | |
| 0.116 | 0.057 | 0.116 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.084 | 0.025 | 0.087 | Carbonic anhydrase IX inhibitor | 0.087 0.024 CID_6115 0.047 0.045 CID_14535 | CID_6115 | |
| 0.139 | 0.08 | 0.165 | Heat shock protein 70 antagonist | 0.165 0.022 CID_6115 0.156 0.034 CID_14535 | CID_6115 | |
| 0.112 | 0.054 | 0.112 | Beta glucuronidase inhibitor | 0.098 0.073 CID_6115 0.1 0.069 CID_14535 | ||
| 0.103 | 0.047 | 0.184 | Protein kinase C zeta inhibitor | 0.175 0.015 CID_6115 0.184 0.013 CID_14535 | CID_14535 | |
| 0.077 | 0.02 | 0.099 | Transcription factor RelA inhibitor | 0.097 0.007 CID_6115 0.099 0.007 CID_14535 | CID_14535 | |
| 0.087 | 0.032 | 0.166 | Carbonic anhydrase V inhibitor | 0.166 0.011 CID_6115 0.109 0.024 CID_14535 | CID_6115 | |
| 0.095 | 0.04 | 0.148 | Catalase inhibitor | 0.148 0.027 CID_6115 0.13 0.031 CID_14535 | CID_6115 | |
| 0.125 | 0.07 | 0.227 | Papain-like protease (SARS coronavirus) inhibitor | 0.227 0.006 CID_6115 0.166 0.022 CID_14535 | CID_6115 | |
| 0.08 | 0.026 | 0.08 | Neuraminidase inhibitor | |||
| 0.169 | 0.115 | 0.24 | Histone acetyltransferase inhibitor | 0.24 0.03 CID_6115 0.218 0.046 CID_14535 | CID_6115 | |
| 0.103 | 0.05 | 0.103 | Uric acid excretion stimulant | |||
| 0.152 | 0.099 | 0.294 | Amyloid beta precursor protein antagonist | 0.294 0.019 CID_6115 | CID_6115 | |
| 0.065 | 0.012 | 0.085 | AICAR transformylase inhibitor | 0.085 0.007 CID_6115 0.063 0.012 CID_14535 | CID_6115 | |
| 0.07 | 0.018 | 0.103 | Ryanodine receptor antagonist | 0.103 0.004 CID_6115 0.072 0.015 CID_14535 | CID_6115 | |
| 0.069 | 0.017 | 0.069 | Beta 2 adrenoreceptor antagonist | 0.057 0.028 CID_6115 0.068 0.018 CID_14535 | ||
| 0.069 | 0.017 | 0.122 | Topoisomerase II beta inhibitor | 0.12 0.007 CID_6115 0.122 0.007 CID_14535 | CID_14535 | |
| 0.093 | 0.042 | 0.217 | Carbonic anhydrase XIII inhibitor | 0.217 0.012 CID_6115 0.179 0.017 CID_14535 | CID_6115 | |
| 0.062 | 0.01 | 0.076 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.076 0.007 CID_14535 | CID_14535 | |
| 0.078 | 0.029 | 0.08 | Beta adrenoreceptor antagonist | 0.066 0.044 CID_6115 0.08 0.027 CID_14535 | CID_14535 | |
| 0.069 | 0.02 | 0.083 | Beta 2 adrenoreceptor agonist | 0.067 0.025 CID_6115 0.083 0.008 CID_14535 | CID_14535 | |
| 0.213 | 0.164 | 0.249 | Apoptosis antagonist | 0.225 0.152 CID_6115 0.249 0.129 CID_14535 | CID_14535 | |
| 0.068 | 0.019 | 0.101 | Dihydroorotate oxidase inhibitor | 0.101 0.005 CID_6115 0.069 0.018 CID_14535 | CID_6115 | |
| 0.068 | 0.02 | 0.128 | Aconitate hydratase inhibitor | 0.128 0.005 CID_6115 0.083 0.013 CID_14535 | CID_6115 | |
| 0.087 | 0.039 | 0.149 | NMDA 2 receptor antagonist | 0.149 0.017 CID_6115 0.131 0.021 CID_14535 | CID_6115 | |
| 0.198 | 0.152 | 0.291 | Gastrin inhibitor | 0.291 0.039 CID_6115 0.213 0.129 CID_14535 | CID_6115 | |
| 0.099 | 0.052 | 0.112 | Bile acid receptor antagonist | 0.112 0.028 CID_6115 0.102 0.045 CID_14535 | CID_6115 | |
| 0.063 | 0.019 | 0.081 | Estradiol 17 beta-dehydrogenase inhibitor | 0.037 0.034 CID_6115 0.081 0.013 CID_14535 | CID_14535 | |
| 0.07 | 0.026 | 0.164 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.164 0.008 CID_6115 0.107 0.013 CID_14535 | CID_6115 | |
| 0.062 | 0.018 | 0.062 | Carbonic anhydrase VII inhibitor | 0.059 0.02 CID_6115 0.051 0.027 CID_14535 | ||
| 0.073 | 0.03 | 0.089 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 CID_6115 0.089 0.018 CID_14535 | CID_14535 | |
| 0.054 | 0.011 | 0.099 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.099 0.003 CID_6115 0.096 0.003 CID_14535 | CID_6115 | |
| 0.099 | 0.057 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | 0.166 0.007 CID_6115 0.121 0.029 CID_14535 | CID_6115 | |
| 0.062 | 0.02 | 0.094 | CD45 antagonist | 0.08 0.012 CID_6115 0.094 0.01 CID_14535 | CID_14535 | |
| 0.058 | 0.017 | 0.098 | NMDA receptor subunit 3A antagonist | 0.08 0.012 CID_6115 0.098 0.009 CID_14535 | CID_14535 | |
| 0.103 | 0.063 | 0.132 | Urease inhibitor | 0.132 0.035 CID_6115 0.111 0.054 CID_14535 | CID_6115 | |
| 0.092 | 0.052 | 0.103 | Bromodomain-containing protein 2 inhibitor | 0.103 0.037 CID_6115 | CID_6115 | |
| 0.069 | 0.03 | 0.084 | Calcium channel P-type blocker | 0.084 0.012 CID_6115 0.078 0.017 CID_14535 | CID_6115 | |
| 0.097 | 0.058 | 0.129 | Potassium channel (Voltage-sensitive) activator | 0.129 0.024 CID_6115 | CID_6115 | |
| 0.061 | 0.022 | 0.061 | Heparanase inhibitor | 0.058 0.026 CID_6115 0.055 0.032 CID_14535 | ||
| 0.058 | 0.02 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_6115 0.058 0.02 CID_14535 | CID_6115 | |
| 0.112 | 0.075 | 0.201 | Beta amyloid protein antagonist | 0.201 0.016 CID_6115 0.12 0.067 CID_14535 | CID_6115 | |
| 0.133 | 0.096 | 0.175 | Phospholipase A2 inhibitor | 0.133 0.096 CID_6115 0.175 0.056 CID_14535 | CID_14535 | |
| 0.141 | 0.104 | 0.141 | Nitric oxide antagonist | |||
| 0.068 | 0.031 | 0.072 | Histone deacetylase SIRT3 inhibitor | 0.072 0.025 CID_6115 0.058 0.054 CID_14535 | CID_6115 | |
| 0.101 | 0.065 | 0.185 | Aminopeptidase B inhibitor | 0.185 0.025 CID_6115 0.142 0.041 CID_14535 | CID_6115 | |
| 0.061 | 0.026 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 CID_14535 | CID_14535 | |
| 0.132 | 0.096 | 0.175 | Neuropeptide Y1 antagonist | 0.175 0.034 CID_6115 0.137 0.087 CID_14535 | CID_6115 | |
| 0.07 | 0.034 | 0.116 | Aromatase inhibitor | 0.092 0.023 CID_6115 0.116 0.019 CID_14535 | CID_14535 | |
| 0.079 | 0.045 | 0.182 | Glutamate dehydrogenase inhibitor | 0.182 0.012 CID_6115 0.121 0.022 CID_14535 | CID_6115 | |
| 0.071 | 0.037 | 0.119 | Glutamate (mGluR6) antagonist | 0.119 0.005 CID_6115 0.098 0.011 CID_14535 | CID_6115 | |
| 0.077 | 0.043 | 0.16 | Glycine receptor agonist | 0.16 0.006 CID_6115 0.11 0.016 CID_14535 | CID_6115 | |
| 0.067 | 0.034 | 0.215 | Biliverdin reductase inhibitor | 0.215 0.005 CID_6115 0.104 0.017 CID_14535 | CID_6115 | |
| 0.068 | 0.036 | 0.185 | Carbamoyl phosphate synthetase inhibitor | 0.185 0.008 CID_6115 0.115 0.017 CID_14535 | CID_6115 | |
| 0.115 | 0.083 | 0.199 | Cyclooxygenase 3 inhibitor | 0.199 0.019 CID_6115 0.146 0.051 CID_14535 | CID_6115 | |
| 0.116 | 0.085 | 0.166 | Cyclooxygenase 1 inhibitor | 0.133 0.068 CID_6115 0.166 0.049 CID_14535 | CID_14535 | |
| 0.04 | 0.009 | 0.058 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.022 0.016 CID_6115 0.058 0.006 CID_14535 | CID_14535 | |
| 0.054 | 0.024 | 0.069 | Dopamine beta hydroxylase inhibitor | 0.069 0.008 CID_6115 0.067 0.01 CID_14535 | CID_6115 | |
| 0.108 | 0.078 | 0.108 | Cholesterol synthesis inhibitor | 0.097 0.092 CID_6115 0.095 0.094 CID_14535 | ||
| 0.128 | 0.098 | 0.207 | Acetylcholine M1 receptor antagonist | 0.173 0.057 CID_6115 0.207 0.039 CID_14535 | CID_14535 | |
| 0.121 | 0.092 | 0.208 | Lipid peroxidase inhibitor | 0.208 0.038 CID_14535 | CID_14535 | |
| 0.13 | 0.101 | 0.147 | Pregnane X receptor agonist | 0.147 0.058 CID_6115 | CID_6115 | |
| 0.054 | 0.027 | 0.054 | Squalene epoxidase inhibitor | 0.053 0.029 CID_6115 | ||
| 0.054 | 0.027 | 0.062 | Alpha 1b adrenoreceptor agonist | 0.053 0.029 CID_6115 0.062 0.017 CID_14535 | CID_14535 | |
| 0.095 | 0.069 | 0.138 | Cyclin-dependent kinase 9 inhibitor | 0.138 0.038 CID_6115 0.089 0.077 CID_14535 | CID_6115 | |
| 0.059 | 0.032 | 0.059 | Leukotriene C antagonist | 0.055 0.042 CID_6115 0.055 0.043 CID_14535 | ||
| 0.057 | 0.031 | 0.057 | Dihydroorotate dehydrogenase inhibitor | 0.048 0.039 CID_14535 | ||
| 0.172 | 0.147 | 0.421 | Interleukin agonist | 0.421 0.016 CID_6115 0.298 0.049 CID_14535 | CID_6115 | |
| 0.101 | 0.076 | 0.136 | Chelator | 0.136 0.042 CID_14535 | CID_14535 | |
| 0.034 | 0.01 | 0.047 | Estrogen-related receptor gamma antagonist | 0.047 0.004 CID_6115 0.039 0.005 CID_14535 | CID_6115 | |
| 0.136 | 0.113 | 0.285 | LIM domain kinase 1 inhibitor | 0.285 0.025 CID_6115 0.241 0.043 CID_14535 | CID_6115 | |
| 0.043 | 0.019 | 0.043 | CF transmembrane conductance regulator antagonist | 0.039 0.03 CID_14535 | ||
| 0.128 | 0.105 | 0.199 | Cyclin-dependent kinase 8 inhibitor | 0.199 0.036 CID_6115 0.179 0.052 CID_14535 | CID_6115 | |
| 0.057 | 0.033 | 0.093 | Immunoglobulin Fc receptor antagonist | 0.093 0.004 CID_6115 0.069 0.012 CID_14535 | CID_6115 | |
| 0.058 | 0.035 | 0.062 | Pregnane X receptor antagonist | 0.062 0.026 CID_6115 0.056 0.041 CID_14535 | CID_6115 | |
| 0.078 | 0.055 | 0.097 | Topoisomerase II alpha inhibitor | 0.097 0.042 CID_14535 | CID_14535 | |
| 0.122 | 0.1 | 0.127 | Farnesoid X receptor antagonist | 0.127 0.089 CID_14535 | CID_14535 | |
| 0.047 | 0.026 | 0.054 | Beta adrenoreceptor agonist | 0.045 0.032 CID_6115 0.054 0.012 CID_14535 | CID_14535 | |
| 0.125 | 0.104 | 0.195 | Hemostatic | 0.178 0.043 CID_6115 0.195 0.034 CID_14535 | CID_14535 | |
| 0.025 | 0.005 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.023 0.007 CID_6115 0.023 0.006 CID_14535 | ||
| 0.041 | 0.021 | 0.1 | Glutamate (mGluR8) agonist | 0.1 0.003 CID_6115 0.058 0.008 CID_14535 | CID_6115 | |
| 0.059 | 0.041 | 0.075 | Sphingosine kinase inhibitor | 0.073 0.022 CID_6115 0.075 0.02 CID_14535 | CID_14535 | |
| 0.042 | 0.024 | 0.05 | GABA uptake inhibitor | 0.049 0.016 CID_6115 0.05 0.016 CID_14535 | CID_14535 | |
| 0.035 | 0.017 | 0.036 | Estrogen-related receptor beta antagonist | 0.036 0.016 CID_14535 | CID_14535 | |
| 0.104 | 0.086 | 0.147 | Acetylcholine muscarinic antagonist | 0.104 0.086 CID_6115 0.147 0.045 CID_14535 | CID_14535 | |
| 0.081 | 0.064 | 0.137 | NMDA receptor antagonist | 0.133 0.03 CID_6115 0.137 0.028 CID_14535 | CID_14535 | |
| 0.055 | 0.038 | 0.087 | Sphingosine kinase 2 inhibitor | 0.087 0.012 CID_6115 0.073 0.019 CID_14535 | CID_6115 | |
| 0.024 | 0.007 | 0.056 | Alpha 2a adrenoreceptor agonist | 0.056 0.004 CID_6115 0.027 0.005 CID_14535 | CID_6115 | |
| 0.09 | 0.074 | 0.197 | Electrolyte absorption antagonist | 0.197 0.009 CID_6115 0.122 0.034 CID_14535 | CID_6115 | |
| 0.047 | 0.031 | 0.1 | Adenylate cyclase 1 inhibitor | 0.1 0.004 CID_6115 0.067 0.014 CID_14535 | CID_6115 | |
| 0.034 | 0.018 | 0.034 | ATP citrate lysase inhibitor | 0.033 0.02 CID_14535 | ||
| 0.032 | 0.017 | 0.043 | Cyclin E2 inhibitor | 0.043 0.011 CID_6115 | CID_6115 | |
| 0.044 | 0.03 | 0.105 | NMDA receptor subunit 3B antagonist | 0.081 0.013 CID_6115 0.105 0.01 CID_14535 | CID_14535 | |
| 0.069 | 0.055 | 0.123 | Aminopeptidase I inhibitor | 0.123 0.019 CID_6115 0.09 0.034 CID_14535 | CID_6115 | |
| 0.06 | 0.047 | 0.102 | I kappa B kinase 2 inhibitor | 0.102 0.012 CID_6115 0.089 0.017 CID_14535 | CID_6115 | |
| 0.033 | 0.021 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.022 CID_14535 | ||
| 0.054 | 0.042 | 0.176 | Argininosuccinate synthase inhibitor | 0.176 0.009 CID_6115 0.097 0.02 CID_14535 | CID_6115 | |
| 0.035 | 0.024 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.009 CID_6115 0.042 0.018 CID_14535 | CID_6115 | |
| 0.096 | 0.085 | 0.165 | Protein kinase C gamma inhibitor | 0.165 0.024 CID_6115 0.143 0.036 CID_14535 | CID_6115 | |
| 0.056 | 0.045 | 0.075 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 CID_6115 0.075 0.02 CID_14535 | CID_14535 | |
| 0.053 | 0.043 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.06 0.035 CID_6115 0.067 0.029 CID_14535 | CID_14535 | |
| 0.07 | 0.06 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_6115 0.086 0.045 CID_14535 | CID_6115 | |
| 0.033 | 0.023 | 0.047 | Protein kinase (CK2) beta inhibitor | 0.047 0.008 CID_6115 0.036 0.017 CID_14535 | CID_6115 | |
| 0.087 | 0.078 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | 0.107 0.049 CID_6115 0.098 0.06 CID_14535 | CID_6115 | |
| 0.126 | 0.117 | 0.158 | MAP kinase 3 inhibitor | 0.151 0.067 CID_6115 0.158 0.056 CID_14535 | CID_14535 | |
| 0.079 | 0.071 | 0.121 | mTOR complex 2 inhibitor | 0.121 0.017 CID_6115 0.099 0.034 CID_14535 | CID_6115 | |
| 0.09 | 0.082 | 0.106 | Cyclin-dependent kinase 2 inhibitor | 0.106 0.064 CID_6115 | CID_6115 | |
| 0.026 | 0.019 | 0.027 | CXC chemokine 2 receptor antagonist | 0.026 0.019 CID_6115 0.027 0.017 CID_14535 | CID_14535 | |
| 0.056 | 0.049 | 0.101 | Cyclin D1 inhibitor | 0.101 0.008 CID_6115 0.072 0.026 CID_14535 | CID_6115 | |
| 0.027 | 0.02 | 0.032 | Hedgehog signaling activator | 0.032 0.01 CID_6115 0.03 0.012 CID_14535 | CID_6115 | |
| 0.074 | 0.067 | 0.112 | Glycine receptor antagonist | 0.112 0.023 CID_6115 0.082 0.053 CID_14535 | CID_6115 | |
| 0.019 | 0.012 | 0.026 | Estrogen-related receptor gamma agonist | 0.026 0.005 CID_6115 0.023 0.007 CID_14535 | CID_6115 | |
| 0.085 | 0.079 | 0.13 | Sphingomyelinase inhibitor | 0.13 0.034 CID_6115 0.112 0.047 CID_14535 | CID_6115 | |
| 0.039 | 0.034 | 0.06 | Kainate receptor agonist | 0.06 0.007 CID_6115 0.048 0.016 CID_14535 | CID_6115 | |
| 0.044 | 0.039 | 0.096 | Estrogen agonist | 0.096 0.018 CID_14535 | CID_14535 | |
| 0.019 | 0.014 | 0.026 | Antibiotic Anthracycline-like | 0.024 0.005 CID_6115 0.026 0.005 CID_14535 | CID_14535 | |
| 0.073 | 0.069 | 0.073 | Opioid kappa receptor antagonist | |||
| 0.112 | 0.108 | 0.131 | Vanilloid 1 agonist | 0.131 0.064 CID_6115 0.124 0.078 CID_14535 | CID_6115 | |
| 0.049 | 0.046 | 0.052 | Leukotriene B4 antagonist | 0.052 0.04 CID_14535 | CID_14535 | |
| 0.037 | 0.034 | 0.037 | Leukotriene C4 antagonist | |||
| 0.04 | 0.037 | 0.061 | Phosphorylase inhibitor | 0.061 0.024 CID_6115 0.044 0.034 CID_14535 | CID_6115 | |
| 0.092 | 0.09 | 0.156 | Mucolytic | 0.156 0.029 CID_6115 0.142 0.037 CID_14535 | CID_6115 | |
| 0.047 | 0.046 | 0.17 | Acyl-CoA dehydrogenase inhibitor | 0.17 0.007 CID_6115 0.082 0.021 CID_14535 | CID_6115 | |
| 0.085 | 0.084 | 0.118 | Interleukin 12 antagonist | 0.101 0.053 CID_6115 0.118 0.031 CID_14535 | CID_14535 | |
| 0.137 | 0.136 | 0.221 | Non-steroidal antiinflammatory agent | 0.221 0.057 CID_6115 0.188 0.081 CID_14535 | CID_6115 | |
| 0.022 | 0.022 | 0.051 | Methionyl aminopeptidase 2 inhibitor | 0.051 0.006 CID_6115 0.027 0.016 CID_14535 | CID_6115 | |
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.005 | 0.005 | 0.007 | Insulin like growth factor 3 antagonist | 0.007 0.004 CID_14535 | CID_14535 | |
| 0.045 | 0.045 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 CID_6115 0.049 0.037 CID_14535 | CID_6115 | |
| 0.11 | 0.111 | 0.2 | Nav1.6 sodium channel blocker | 0.2 0.019 CID_6115 0.151 0.053 CID_14535 | CID_6115 | |
| 0.054 | 0.055 | 0.151 | NMDA 2C receptor antagonist | 0.151 0.007 CID_6115 0.113 0.012 CID_14535 | CID_6115 | |
| 0.065 | 0.066 | 0.078 | CDC25A inhibitor | 0.078 0.046 CID_14535 | CID_14535 | |
| 0.038 | 0.039 | 0.049 | Purinergic P2Y antagonist | 0.049 0.027 CID_6115 | CID_6115 | |
| 0.026 | 0.028 | 0.046 | Purinergic P2Y15 antagonist | 0.046 0.005 CID_6115 0.036 0.009 CID_14535 | CID_6115 | |
| 0.037 | 0.039 | 0.059 | Guanylate cyclase inhibitor | 0.059 0.012 CID_6115 0.042 0.03 CID_14535 | CID_6115 | |
| 0.013 | 0.016 | 0.022 | Purinergic P2Y1 agonist | 0.022 0.006 CID_6115 0.016 0.01 CID_14535 | CID_6115 | |
| 0.192 | 0.195 | 0.284 | Calpain 2 inhibitor | 0.284 0.124 CID_6115 0.206 0.182 CID_14535 | CID_6115 | |
| 0.113 | 0.116 | 0.153 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.037 CID_6115 0.121 0.094 CID_14535 | CID_6115 | |
| 0.006 | 0.009 | 0.013 | DNA topoisomerase III inhibitor | 0.013 0.003 CID_6115 0.007 0.006 CID_14535 | CID_6115 | |
| 0.068 | 0.072 | 0.128 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.103 0.034 CID_6115 0.128 0.022 CID_14535 | CID_14535 | |
| 0.189 | 0.193 | 0.297 | Vasodilator, coronary | 0.297 0.09 CID_6115 0.261 0.123 CID_14535 | CID_6115 | |
| 0.009 | 0.013 | 0.019 | Glutamate (mGluR6) agonist | 0.019 0.004 CID_6115 0.016 0.005 CID_14535 | CID_6115 | |
| 0.029 | 0.033 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 CID_6115 0.038 0.013 CID_14535 | CID_6115 | |
| 0.05 | 0.054 | 0.063 | Acetylcholine M3 receptor antagonist | 0.063 0.037 CID_14535 | CID_14535 | |
| 0.038 | 0.043 | 0.049 | Dihydroorotase inhibitor | 0.049 0.026 CID_6115 | CID_6115 | |
| 0.051 | 0.056 | 0.146 | NMDA receptor glycine site agonist | 0.146 0.005 CID_6115 0.09 0.022 CID_14535 | CID_6115 | |
| 0.072 | 0.077 | 0.165 | Histamine N-methyltransferase inhibitor | 0.165 0.01 CID_6115 0.13 0.023 CID_14535 | CID_6115 | |
| 0.013 | 0.018 | 0.018 | Thromboxane A2 agonist | 0.018 0.008 CID_6115 | CID_6115 | |
| 0.034 | 0.04 | 0.037 | Vanilloid 3 antagonist | 0.037 0.029 CID_6115 0.036 0.035 CID_14535 | CID_6115 | |
| 0.022 | 0.028 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_6115 0.024 0.02 CID_14535 | CID_6115 | |
| 0.033 | 0.039 | 0.062 | Potassium channel Kv1.1 blocker | 0.062 0.008 CID_6115 0.035 0.033 CID_14535 | CID_6115 | |
| 0.132 | 0.138 | 0.239 | 3C-like protease (Human coronavirus) inhibitor | 0.239 0.032 CID_6115 0.15 0.102 CID_14535 | CID_6115 | |
| 0.037 | 0.043 | 0.071 | Nerve growth factor antagonist | 0.071 0.005 CID_6115 0.05 0.018 CID_14535 | CID_6115 | |
| 0.055 | 0.062 | 0.057 | Heme oxygenase stimulant | 0.057 0.054 CID_14535 | CID_14535 | |
| 0.026 | 0.032 | 0.028 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.028 0.027 CID_14535 | CID_14535 | |
| 0.014 | 0.021 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_6115 0.016 0.014 CID_14535 | CID_6115 | |
| 0.027 | 0.035 | 0.074 | Fumarate hydratase inhibitor | 0.074 0.008 CID_6115 0.042 0.018 CID_14535 | CID_6115 | |
| 0.136 | 0.144 | 0.141 | Death-associated protein kinase 2 inhibitor | 0.141 0.128 CID_6115 | CID_6115 | |
| 0.04 | 0.048 | 0.096 | Carbonic anhydrase XIV inhibitor | 0.096 0.012 CID_6115 0.071 0.02 CID_14535 | CID_6115 | |
| 0.035 | 0.044 | 0.046 | Sphingosine kinase 1 inhibitor | 0.046 0.021 CID_6115 0.043 0.025 CID_14535 | CID_6115 | |
| 0.049 | 0.058 | 0.075 | Androgen agonist | 0.075 0.027 CID_6115 0.057 0.046 CID_14535 | CID_6115 | |
| 0.084 | 0.093 | 0.108 | Phosphodiesterase 6D inhibitor | 0.108 0.039 CID_6115 0.091 0.072 CID_14535 | CID_6115 | |
| 0.011 | 0.02 | 0.028 | NMDA receptor phencyclidine site antagonist | 0.028 0.005 CID_6115 0.016 0.01 CID_14535 | CID_6115 | |
| 0.019 | 0.029 | 0.063 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.063 0.007 CID_6115 0.042 0.011 CID_14535 | CID_6115 | |
| 0.01 | 0.02 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CID_6115 | CID_6115 | |
| 0.017 | 0.028 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 CID_6115 0.025 0.017 CID_14535 | CID_6115 | |
| 0.022 | 0.033 | 0.04 | Complement factor 1s inhibitor | 0.04 0.004 CID_6115 0.028 0.011 CID_14535 | CID_6115 | |
| 0.039 | 0.05 | 0.057 | Heme oxygenase inhibitor | 0.057 0.008 CID_6115 0.041 0.04 CID_14535 | CID_6115 | |
| 0.075 | 0.087 | 0.094 | 5-Lipoxygenase inhibitor | 0.094 0.068 CID_14535 | CID_14535 | |
| 0.049 | 0.061 | 0.066 | Acetylcholine M5 receptor antagonist | 0.057 0.047 CID_6115 0.066 0.034 CID_14535 | CID_14535 | |
| 0.035 | 0.047 | 0.072 | Geranyltranstransferase inhibitor | 0.072 0.007 CID_6115 0.051 0.022 CID_14535 | CID_6115 | |
| 0.017 | 0.03 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.015 CID_14535 | CID_14535 | |
| 0.083 | 0.096 | 0.201 | DNA intercalator | 0.106 0.067 CID_6115 0.201 0.025 CID_14535 | CID_14535 | |
| 0.021 | 0.034 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 CID_6115 | CID_6115 | |
| 0.018 | 0.031 | 0.103 | Estrogen receptor beta agonist | 0.103 0.011 CID_14535 | CID_14535 | |
| 0.029 | 0.042 | 0.065 | Diamine oxidase inhibitor | 0.065 0.008 CID_6115 0.037 0.027 CID_14535 | CID_6115 | |
| 0.061 | 0.075 | 0.104 | Phospholipase D inhibitor | 0.104 0.013 CID_6115 0.078 0.038 CID_14535 | CID_6115 | |
| 0.036 | 0.049 | 0.066 | GABA B receptor antagonist | 0.066 0.01 CID_6115 0.049 0.021 CID_14535 | CID_6115 | |
| 0.086 | 0.1 | 0.119 | Folate antagonist | 0.119 0.039 CID_6115 | CID_6115 | |
| 0.047 | 0.061 | 0.054 | DNA helicase inhibitor | 0.054 0.038 CID_14535 | CID_14535 | |
| 0.03 | 0.045 | 0.156 | Dihydropteroate synthase inhibitor | 0.156 0.003 CID_6115 0.064 0.01 CID_14535 | CID_6115 | |
| 0.092 | 0.107 | 0.142 | Microtubule formation inhibitor | 0.142 0.042 CID_6115 0.142 0.042 CID_14535 | CID_14535 | |
| 0.017 | 0.032 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CID_6115 | CID_6115 | |
| 0.044 | 0.059 | 0.079 | Alpha-mannosidase inhibitor | 0.079 0.012 CID_6115 0.057 0.031 CID_14535 | CID_6115 | |
| 0.027 | 0.043 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | 0.054 0.013 CID_6115 | CID_6115 | |
| 0.047 | 0.064 | 0.119 | Alpha 2 adrenoreceptor agonist | 0.119 0.01 CID_6115 0.073 0.029 CID_14535 | CID_6115 | |
| 0.036 | 0.053 | 0.078 | Dihydrofolate reductase inhibitor | 0.078 0.005 CID_6115 0.051 0.017 CID_14535 | CID_6115 | |
| 0.022 | 0.039 | 0.03 | Sirtuin 2 inhibitor | 0.03 0.025 CID_14535 | CID_14535 | |
| 0.014 | 0.031 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_6115 | CID_6115 | |
| 0.122 | 0.139 | 0.152 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.128 0.12 CID_6115 0.152 0.069 CID_14535 | CID_14535 | |
| 0.059 | 0.076 | 0.072 | MAP3K7 inhibitor | 0.072 0.05 CID_6115 | CID_6115 | |
| 0.034 | 0.052 | 0.079 | Thymidylate synthase inhibitor | 0.079 0.008 CID_6115 0.059 0.018 CID_14535 | CID_6115 | |
| 0.012 | 0.031 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.009 CID_14535 | CID_14535 | |
| 0.006 | 0.025 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CID_6115 | CID_6115 | |
| 0.006 | 0.025 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.005 CID_6115 | CID_6115 | |
| 0.059 | 0.078 | 0.146 | CYP2A6 inhibitor | 0.146 0.018 CID_6115 0.084 0.045 CID_14535 | CID_6115 | |
| 0.022 | 0.042 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 CID_6115 | CID_6115 | |
| 0.015 | 0.035 | 0.05 | Glutamate (mGluR1a) agonist | 0.05 0.005 CID_6115 0.022 0.015 CID_14535 | CID_6115 | |
| 0.026 | 0.046 | 0.041 | Histone deacetylase 7 inhibitor | 0.041 0.022 CID_6115 | CID_6115 | |
| 0.027 | 0.047 | 0.07 | Glutamate (mGluR4) agonist | 0.07 0.007 CID_6115 0.033 0.026 CID_14535 | CID_6115 | |
| 0.052 | 0.072 | 0.101 | Histone deacetylase inhibitor | 0.101 0.018 CID_6115 0.071 0.039 CID_14535 | CID_6115 | |
| 0.051 | 0.072 | 0.102 | Alpha adrenoreceptor agonist | 0.102 0.027 CID_6115 0.071 0.044 CID_14535 | CID_6115 | |
| 0.017 | 0.038 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 CID_6115 | CID_6115 | |
| 0.026 | 0.047 | 0.091 | Kainate receptor antagonist | 0.091 0.008 CID_6115 0.037 0.032 CID_14535 | CID_6115 | |
| 0.028 | 0.05 | 0.055 | Oxytocin agonist | 0.055 0.021 CID_6115 0.044 0.028 CID_14535 | CID_6115 | |
| 0.017 | 0.039 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 CID_6115 0.023 0.016 CID_14535 | CID_6115 | |
| 0.031 | 0.053 | 0.044 | Histone deacetylase 9 inhibitor | 0.044 0.021 CID_6115 | CID_6115 | |
| 0.028 | 0.05 | 0.072 | Carbonic anhydrase IV inhibitor | 0.072 0.014 CID_6115 0.041 0.032 CID_14535 | CID_6115 | |
| 0.067 | 0.09 | 0.087 | Glutathione S-transferase inhibitor | 0.087 0.051 CID_6115 | CID_6115 | |
| 0.013 | 0.036 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.007 CID_6115 | CID_6115 | |
| 0.033 | 0.056 | 0.072 | Mannosidase inhibitor | 0.072 0.011 CID_6115 0.047 0.029 CID_14535 | CID_6115 | |
| 0.016 | 0.039 | 0.039 | Uridine phosphorylase inhibitor | 0.039 0.012 CID_6115 | CID_6115 | |
| 0.006 | 0.03 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_6115 | CID_6115 | |
| 0.087 | 0.111 | 0.128 | Acetylcholine antagonist | 0.128 0.063 CID_14535 | CID_14535 | |
| 0.089 | 0.113 | 0.131 | Cholinergic antagonist | 0.131 0.064 CID_14535 | CID_14535 | |
| 0.018 | 0.042 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 CID_6115 | CID_6115 | |
| 0.05 | 0.074 | 0.08 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.08 0.019 CID_6115 0.061 0.041 CID_14535 | CID_6115 | |
| 0.023 | 0.047 | 0.047 | Retinoid X alpha receptor agonist | 0.047 0.016 CID_6115 | CID_6115 | |
| 0.029 | 0.054 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 CID_6115 0.04 0.015 CID_14535 | CID_6115 | |
| 0.048 | 0.073 | 0.165 | NMDA receptor agonist | 0.165 0.006 CID_6115 0.081 0.028 CID_14535 | CID_6115 | |
| 0.014 | 0.04 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 CID_6115 | CID_6115 | |
| 0.043 | 0.07 | 0.084 | Carbonic anhydrase stimulant | 0.084 0.024 CID_6115 0.055 0.047 CID_14535 | CID_6115 | |
| 0.119 | 0.146 | 0.242 | Tumour necrosis factor antagonist | 0.242 0.033 CID_6115 0.162 0.085 CID_14535 | CID_6115 | |
| 0.046 | 0.073 | 0.061 | Dopamine D1 antagonist | 0.061 0.049 CID_14535 | CID_14535 | |
| 0.022 | 0.05 | 0.037 | Nicotinic acid receptor agonist | 0.037 0.023 CID_6115 | CID_6115 | |
| 0.032 | 0.06 | 0.058 | Ribonucleoside-diphosphate reductase inhibitor | 0.058 0.035 CID_6115 | CID_6115 | |
| 0.019 | 0.047 | 0.047 | Integrin alpha2beta1 antagonist | 0.047 0.005 CID_6115 | CID_6115 | |
| 0.082 | 0.11 | 0.137 | Glutamate (mGluR7) agonist | 0.137 0.017 CID_6115 | CID_6115 | |
| 0.026 | 0.054 | 0.04 | Urate transporter 1 inhibitor | 0.04 0.026 CID_6115 0.037 0.029 CID_14535 | CID_6115 | |
| 0.026 | 0.054 | 0.066 | Glutamate (mGluR3) antagonist | 0.066 0.007 CID_6115 0.046 0.015 CID_14535 | CID_6115 | |
| 0.064 | 0.092 | 0.132 | I kappa B kinase inhibitor | 0.132 0.021 CID_6115 0.104 0.035 CID_14535 | CID_6115 | |
| 0.041 | 0.07 | 0.054 | Alpha 1 adrenoreceptor agonist | 0.054 0.045 CID_6115 | CID_6115 | |
| 0.009 | 0.039 | 0.03 | Cyclin T1 inhibitor | 0.03 0.005 CID_6115 | CID_6115 | |
| 0.031 | 0.062 | 0.06 | Ribonucleotide reductase inhibitor | 0.06 0.036 CID_6115 | CID_6115 | |
| 0.014 | 0.045 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 CID_6115 | CID_6115 | |
| 0.12 | 0.151 | 0.158 | MAP kinase kinase 4 inhibitor | 0.158 0.048 CID_6115 0.156 0.051 CID_14535 | CID_6115 | |
| 0.043 | 0.074 | 0.109 | Epithelial sodium channel blocker | 0.109 0.005 CID_6115 0.061 0.027 CID_14535 | CID_6115 | |
| 0.03 | 0.062 | 0.12 | Glutamate (mGluR group III) agonist | 0.12 0.007 CID_6115 0.043 0.03 CID_14535 | CID_6115 | |
| 0.015 | 0.047 | 0.049 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.049 0.004 CID_6115 0.03 0.008 CID_14535 | CID_6115 | |
| 0.039 | 0.072 | 0.089 | Lysine-specific demethylase 1A inhibitor | 0.089 0.009 CID_6115 0.074 0.015 CID_14535 | CID_6115 | |
| 0.035 | 0.068 | 0.064 | Potassium channel (Inward rectifier) blocker | 0.064 0.021 CID_6115 | CID_6115 | |
| 0.052 | 0.085 | 0.114 | Potassium channel (ATP-sensitive) blocker | 0.114 0.01 CID_6115 0.065 0.051 CID_14535 | CID_6115 | |
| 0.08 | 0.113 | 0.166 | Interleukin 1b antagonist | 0.166 0.03 CID_6115 0.165 0.031 CID_14535 | CID_6115 | |
| 0.056 | 0.089 | 0.104 | Exportin-1 inhibitor | 0.104 0.007 CID_6115 | CID_6115 | |
| 0.002 | 0.036 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 CID_6115 | CID_6115 | |
| 0.019 | 0.053 | 0.03 | Thymidine phosphorylase inhibitor | 0.03 0.012 CID_6115 | CID_6115 | |
| 0.029 | 0.063 | 0.078 | AMPA 4 receptor antagonist | 0.078 0.007 CID_6115 0.042 0.023 CID_14535 | CID_6115 | |
| 0.051 | 0.085 | 0.081 | Protein kinase C beta inhibitor | 0.081 0.028 CID_6115 0.066 0.057 CID_14535 | CID_6115 | |
| 0.024 | 0.058 | 0.039 | Histone deacetylase 8 inhibitor | 0.039 0.031 CID_6115 | CID_6115 | |
| 0.043 | 0.078 | 0.054 | 5 Hydroxytryptamine 7 agonist | 0.054 0.042 CID_6115 | CID_6115 | |
| 0.031 | 0.065 | 0.092 | Fructose-1,6-bisphosphatase inhibitor | 0.092 0.005 CID_6115 0.063 0.016 CID_14535 | CID_6115 | |
| 0.026 | 0.061 | 0.062 | Integrin alpha2 antagonist | 0.062 0.007 CID_6115 | CID_6115 | |
| 0.044 | 0.08 | 0.113 | Sphingosine 1-phosphate receptor 4 agonist | 0.113 0.019 CID_6115 0.08 0.036 CID_14535 | CID_6115 | |
| 0.006 | 0.041 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.006 CID_6115 | CID_6115 | |
| 0.029 | 0.065 | 0.056 | Thymidine kinase inhibitor | 0.056 0.015 CID_6115 | CID_6115 | |
| 0.01 | 0.046 | 0.033 | Alpha 2c adrenoreceptor agonist | 0.033 0.004 CID_6115 | CID_6115 | |
| 0.024 | 0.06 | 0.065 | Histone deacetylase class I inhibitor | 0.065 0.014 CID_6115 0.039 0.027 CID_14535 | CID_6115 | |
| 0.028 | 0.064 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.036 CID_6115 | CID_6115 | |
| 0.007 | 0.044 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_6115 | CID_6115 | |
| 0.019 | 0.056 | 0.04 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.012 CID_6115 | CID_6115 | |
| 0.023 | 0.06 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 CID_6115 | CID_6115 | |
| 0.071 | 0.108 | 0.082 | Hematopoietic | 0.082 0.067 CID_6115 | CID_6115 | |
| 0.08 | 0.118 | 0.106 | Proteasome inhibitor | 0.106 0.079 CID_6115 | CID_6115 | |
| 0.03 | 0.068 | 0.103 | Ornithine carbamoyltransferase inhibitor | 0.103 0.015 CID_6115 0.054 0.036 CID_14535 | CID_6115 | |
| 0.001 | 0.039 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 CID_6115 | CID_6115 | |
| 0.084 | 0.124 | 0.234 | MAP kinase 12 inhibitor | 0.137 0.052 CID_6115 0.234 0.014 CID_14535 | CID_14535 | |
| 0.007 | 0.047 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 CID_6115 | CID_6115 | |
| 0.007 | 0.047 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 CID_6115 | CID_6115 | |
| 0.014 | 0.054 | 0.047 | Lysine carboxypeptidase inhibitor | 0.047 0.008 CID_6115 | CID_6115 | |
| 0.065 | 0.105 | 0.092 | Caspase 7 inhibitor | 0.092 0.038 CID_6115 | CID_6115 | |
| 0.006 | 0.047 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.009 CID_6115 | CID_6115 | |
| 0.017 | 0.058 | 0.039 | Retinoid X receptor agonist | 0.039 0.023 CID_6115 | CID_6115 | |
| 0.071 | 0.112 | 0.146 | Expectorant | 0.146 0.037 CID_6115 0.133 0.043 CID_14535 | CID_6115 | |
| 0.083 | 0.126 | 0.102 | CDC-like kinase 3 inhibitor | 0.102 0.076 CID_6115 0.102 0.074 CID_14535 | CID_14535 | |
| 0.013 | 0.057 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 CID_6115 | CID_6115 | |
| 0.016 | 0.061 | 0.033 | Glutamate (mGluR1) agonist | 0.033 0.008 CID_6115 | CID_6115 | |
| 0.098 | 0.143 | 0.184 | Cell wall synthesis inhibitor | 0.184 0.038 CID_6115 0.158 0.058 CID_14535 | CID_6115 | |
| 0.081 | 0.127 | 0.429 | Tubulin antagonist | 0.157 0.055 CID_6115 0.429 0.01 CID_14535 | CID_14535 | |
| 0.06 | 0.105 | 0.089 | Vanilloid 4 agonist | 0.089 0.027 CID_6115 | CID_6115 | |
| 0.019 | 0.064 | 0.037 | 5 Hydroxytryptamine 6 agonist | 0.037 0.009 CID_6115 | CID_6115 | |
| 0.031 | 0.077 | 0.071 | Glutamate (mGluR4) antagonist | 0.071 0.01 CID_6115 0.043 0.03 CID_14535 | CID_6115 | |
| 0.129 | 0.175 | 0.265 | Immunostimulant | 0.265 0.09 CID_6115 0.184 0.13 CID_14535 | CID_6115 | |
| 0.009 | 0.056 | 0.03 | Adenosine kinase inhibitor | 0.03 0.01 CID_6115 | CID_6115 | |
| 0.072 | 0.118 | 0.147 | Alpha 2b adrenoreceptor antagonist | 0.147 0.04 CID_6115 0.109 0.067 CID_14535 | CID_6115 | |
| 0.025 | 0.072 | 0.07 | Adenosine deaminase inhibitor | 0.07 0.014 CID_6115 0.055 0.025 CID_14535 | CID_6115 | |
| 0.032 | 0.079 | 0.077 | Alpha tubulin antagonist | 0.077 0.021 CID_6115 0.07 0.024 CID_14535 | CID_6115 | |
| 0.032 | 0.08 | 0.067 | Glutamate (mGluR group III) antagonist | 0.067 0.01 CID_6115 0.046 0.026 CID_14535 | CID_6115 | |
| 0.055 | 0.104 | 0.096 | Androgen antagonist | 0.089 0.056 CID_6115 0.096 0.05 CID_14535 | CID_14535 | |
| 0.044 | 0.092 | 0.119 | 5 Hydroxytryptamine 3 agonist | 0.119 0.009 CID_6115 0.065 0.041 CID_14535 | CID_6115 | |
| 0.039 | 0.087 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.035 CID_6115 | CID_6115 | |
| 0.07 | 0.12 | 0.18 | MAP kinase kinase 1 inhibitor | 0.18 0.008 CID_6115 0.144 0.019 CID_14535 | CID_6115 | |
| 0.013 | 0.062 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | 0.023 0.012 CID_6115 | CID_6115 | |
| 0.017 | 0.067 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 CID_6115 | CID_6115 | |
| 0.006 | 0.056 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 CID_6115 | CID_6115 | |
| 0.011 | 0.061 | 0.037 | Kynurenine 3 monooxygenase inhibitor | 0.037 0.011 CID_6115 | CID_6115 | |
| 0.023 | 0.073 | 0.032 | Melatonin receptor 1A agonist | 0.032 0.027 CID_6115 | CID_6115 | |
| 0.064 | 0.115 | 0.132 | Pim-3 kinase inhibitor | 0.132 0.025 CID_6115 0.089 0.059 CID_14535 | CID_6115 | |
| 0.008 | 0.059 | 0.019 | Adenosine A2 receptor agonist | 0.019 0.009 CID_6115 | CID_6115 | |
| 0.062 | 0.113 | 0.136 | Bronchodilator | 0.136 0.037 CID_14535 | CID_14535 | |
| 0.083 | 0.134 | 0.18 | Acetylcholinesterase inhibitor | 0.18 0.04 CID_6115 | CID_6115 | |
| 0.005 | 0.057 | 0.018 | Adenosine A2a receptor agonist | 0.018 0.009 CID_6115 | CID_6115 | |
| 0.024 | 0.076 | 0.054 | Membrane dipeptidase inhibitor | 0.054 0.013 CID_6115 | CID_6115 | |
| 0.033 | 0.086 | 0.053 | Benzodiazepine antagonist | 0.053 0.022 CID_6115 | CID_6115 | |
| 0.015 | 0.068 | 0.042 | Nicotinic alpha3beta4 receptor agonist | 0.042 0.009 CID_6115 | CID_6115 | |
| 0.008 | 0.062 | 0.028 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.028 0.009 CID_6115 | CID_6115 | |
| 0.015 | 0.07 | 0.088 | Potassium channel small-conductance Ca-activated activator | 0.088 0.005 CID_6115 | CID_6115 | |
| 0.028 | 0.083 | 0.089 | Beta tubulin antagonist | 0.073 0.033 CID_6115 0.089 0.026 CID_14535 | CID_14535 | |
| 0.053 | 0.108 | 0.103 | Adenosine A3 receptor antagonist | 0.103 0.025 CID_6115 | CID_6115 | |
| 0.062 | 0.118 | 0.103 | Mediator release inhibitor | 0.103 0.066 CID_6115 0.101 0.069 CID_14535 | CID_6115 | |
| 0.024 | 0.082 | 0.103 | AMPA receptor antagonist | 0.103 0.011 CID_6115 0.05 0.031 CID_14535 | CID_6115 | |
| 0.011 | 0.07 | 0.05 | AMPA 3 receptor antagonist | 0.05 0.009 CID_6115 | CID_6115 | |
| 0.01 | 0.07 | 0.017 | CC chemokine 9 receptor antagonist | 0.017 0.012 CID_6115 | CID_6115 | |
| 0.034 | 0.094 | 0.064 | Potassium channel (Inward rectifier) activator | 0.064 0.016 CID_6115 | CID_6115 | |
| 0.033 | 0.093 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_6115 | CID_6115 | |
| 0.02 | 0.08 | 0.041 | Purinergic P2Y2 antagonist | 0.041 0.015 CID_6115 0.037 0.019 CID_14535 | CID_6115 | |
| 0.009 | 0.069 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_6115 | CID_6115 | |
| 0.084 | 0.145 | 0.239 | Toll-Like receptor 9 antagonist | 0.239 0.023 CID_6115 0.152 0.062 CID_14535 | CID_6115 | |
| 0.008 | 0.068 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 CID_6115 | CID_6115 | |
| 0.072 | 0.133 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.079 CID_6115 0.091 0.083 CID_14535 | CID_6115 | |
| 0.031 | 0.092 | 0.079 | GABA receptor antagonist | 0.079 0.022 CID_6115 | CID_6115 | |
| 0.088 | 0.15 | 0.167 | Activin receptor-like kinase 2 inhibitor | 0.167 0.055 CID_6115 0.127 0.088 CID_14535 | CID_6115 | |
| 0.016 | 0.078 | 0.042 | Methionyl aminopeptidase 1 inhibitor | 0.042 0.01 CID_6115 | CID_6115 | |
| 0.022 | 0.085 | 0.052 | CDK5/p25 inhibitor | 0.052 0.02 CID_6115 | CID_6115 | |
| 0.048 | 0.112 | 0.104 | Calcium antagonist | 0.104 0.045 CID_6115 | CID_6115 | |
| 0.013 | 0.077 | 0.038 | Protein 30S ribosomal subunit inhibitor | 0.038 0.01 CID_14535 | CID_14535 | |
| 0.008 | 0.072 | 0.055 | Dopamine autoreceptor agonist | 0.055 0.006 CID_6115 0.023 0.017 CID_14535 | CID_6115 | |
| 0.08 | 0.145 | 0.138 | Cytokine production inhibitor | 0.138 0.072 CID_6115 | CID_6115 | |
| 0.054 | 0.121 | 0.084 | MDM2 inhibitor | 0.084 0.016 CID_6115 | CID_6115 | |
| 0.014 | 0.081 | 0.047 | CDK4/cyclin D3 inhibitor | 0.047 0.008 CID_6115 | CID_6115 | |
| 0.029 | 0.097 | 0.076 | GABA A receptor antagonist | 0.076 0.023 CID_6115 | CID_6115 | |
| 0.033 | 0.102 | 0.078 | Cytokine production stimulant | 0.078 0.005 CID_6115 0.051 0.026 CID_14535 | CID_6115 | |
| 0.034 | 0.104 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | 0.07 0.026 CID_6115 | CID_6115 | |
| 0.003 | 0.073 | 0.01 | Angiotensin AT2 receptor agonist | 0.01 0.008 CID_6115 | CID_6115 | |
| 0.015 | 0.087 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 CID_6115 | CID_6115 | |
| 0.113 | 0.185 | 0.471 | Lipocortins synthesis antagonist | 0.471 0.005 CID_6115 0.227 0.042 CID_14535 | CID_6115 | |
| 0.021 | 0.094 | 0.051 | Antimetabolite | 0.051 0.031 CID_6115 | CID_6115 | |
| 0.045 | 0.119 | 0.079 | Phosphodiesterase 1C inhibitor | 0.079 0.02 CID_6115 | CID_6115 | |
| 0.014 | 0.09 | 0.057 | Histone deacetylase 2 inhibitor | 0.057 0.013 CID_6115 | CID_6115 | |
| 0.07 | 0.146 | 0.132 | Glycogen synthase kinase-3 alpha inhibitor | 0.132 0.077 CID_6115 0.106 0.098 CID_14535 | CID_6115 | |
| 0.032 | 0.108 | 0.061 | Cyclin A2 inhibitor | 0.061 0.046 CID_6115 | CID_6115 | |
| 0.015 | 0.092 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.034 0.017 CID_6115 | CID_6115 | |
| 0.027 | 0.104 | 0.112 | Maillard reaction inhibitor | 0.112 0.013 CID_6115 0.053 0.04 CID_14535 | CID_6115 | |
| 0.085 | 0.163 | 0.205 | Interleukin 1 antagonist | 0.205 0.031 CID_6115 0.182 0.041 CID_14535 | CID_6115 | |
| 0.041 | 0.12 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 CID_6115 | CID_6115 | |
| 0.008 | 0.088 | 0.052 | Arginase inhibitor | 0.052 0.014 CID_6115 0.033 0.028 CID_14535 | CID_6115 | |
| 0.077 | 0.158 | 0.181 | Acetylcholine release stimulant | 0.181 0.005 CID_6115 0.115 0.057 CID_14535 | CID_6115 | |
| 0.043 | 0.124 | 0.107 | Interferon inducer | 0.107 0.01 CID_6115 0.07 0.035 CID_14535 | CID_6115 | |
| 0.015 | 0.097 | 0.04 | MAP3K8 inhibitor | 0.04 0.007 CID_6115 | CID_6115 | |
| 0.012 | 0.093 | 0.056 | Kainate receptor 2 antagonist | 0.056 0.013 CID_6115 | CID_6115 | |
| 0.028 | 0.11 | 0.052 | Dopamine uptake inhibitor | 0.052 0.046 CID_6115 | CID_6115 | |
| 0.009 | 0.091 | 0.083 | Histone deacetylase 1 inhibitor | 0.083 0.009 CID_6115 0.023 0.018 CID_14535 | CID_6115 | |
| 0.035 | 0.118 | 0.049 | Factor III inhibitor | 0.049 0.037 CID_6115 | CID_6115 | |
| 0.04 | 0.124 | 0.078 | Cathepsin G inhibitor | 0.078 0.045 CID_6115 | CID_6115 | |
| 0.052 | 0.137 | 0.077 | Chymotrypsin inhibitor | 0.077 0.058 CID_6115 | CID_6115 | |
| 0.029 | 0.114 | 0.057 | Cyclin A inhibitor | 0.057 0.047 CID_6115 | CID_6115 | |
| 0.167 | 0.254 | 0.5 | Interleukin 2 agonist | 0.5 0.008 CID_6115 0.32 0.061 CID_14535 | CID_6115 | |
| 0.04 | 0.128 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.03 CID_6115 | CID_6115 | |
| 0.045 | 0.133 | 0.1 | Acetylcholine nicotinic agonist | 0.1 0.037 CID_6115 | CID_6115 | |
| 0.026 | 0.115 | 0.064 | Histamine H1 receptor agonist | 0.064 0.006 CID_6115 | CID_6115 | |
| 0.012 | 0.101 | 0.032 | Factor XIII inhibitor | 0.032 0.004 CID_6115 | CID_6115 | |
| 0.042 | 0.131 | 0.075 | Alpha 2a adrenoreceptor antagonist | 0.075 0.052 CID_6115 | CID_6115 | |
| 0.007 | 0.097 | 0.023 | Complement factor D inhibitor | 0.023 0.006 CID_6115 | CID_6115 | |
| 0.005 | 0.095 | 0.042 | AMPA 1 receptor antagonist | 0.042 0.014 CID_6115 | CID_6115 | |
| 0.013 | 0.103 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.022 CID_6115 | CID_6115 | |
| 0.15 | 0.241 | 0.314 | Vasodilator, peripheral | 0.299 0.097 CID_6115 0.314 0.09 CID_14535 | CID_14535 | |
| 0.039 | 0.131 | 0.077 | 5 Hydroxytryptamine 5A antagonist | 0.077 0.025 CID_6115 0.055 0.054 CID_14535 | CID_6115 | |
| 0.05 | 0.143 | 0.088 | Topoisomerase I inhibitor | 0.088 0.081 CID_14535 | CID_14535 | |
| 0.021 | 0.114 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 CID_6115 | CID_6115 | |
| 0.047 | 0.141 | 0.143 | Interferon agonist | 0.143 0.011 CID_6115 0.089 0.04 CID_14535 | CID_6115 | |
| 0.031 | 0.126 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.038 CID_6115 | CID_6115 | |
| 0.05 | 0.147 | 0.082 | GABA A receptor agonist | 0.082 0.06 CID_6115 | CID_6115 | |
| 0.017 | 0.116 | 0.03 | Glucosylceramidase stimulant | 0.03 0.013 CID_6115 | CID_6115 | |
| 0.075 | 0.173 | 0.168 | Nav1.2 sodium channel blocker | 0.168 0.047 CID_6115 0.119 0.084 CID_14535 | CID_6115 | |
| 0.057 | 0.155 | 0.119 | Alpha 2c adrenoreceptor antagonist | 0.119 0.05 CID_6115 | CID_6115 | |
| 0.064 | 0.164 | 0.202 | MAP kinase kinase inhibitor | 0.202 0.028 CID_6115 0.184 0.035 CID_14535 | CID_6115 | |
| 0.037 | 0.137 | 0.081 | Potassium channel intermediate-conductance Ca-activated blocker | 0.081 0.017 CID_6115 | CID_6115 | |
| 0.051 | 0.151 | 0.095 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.095 0.044 CID_6115 | CID_6115 | |
| 0.112 | 0.212 | 0.27 | Spasmolytic | 0.206 0.115 CID_6115 0.27 0.083 CID_14535 | CID_14535 | |
| 0.022 | 0.124 | 0.047 | 5 Hydroxytryptamine 2B agonist | 0.047 0.015 CID_6115 | CID_6115 | |
| 0.032 | 0.134 | 0.06 | MAP kinase kinase 9 inhibitor | 0.06 0.031 CID_6115 | CID_6115 | |
| 0.055 | 0.157 | 0.107 | Phosphodiesterase I inhibitor | 0.107 0.037 CID_6115 | CID_6115 | |
| 0.009 | 0.111 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.01 CID_6115 | CID_6115 | |
| 0.007 | 0.109 | 0.022 | CDK2/cyclin A3 inhibitor | 0.022 0.004 CID_6115 | CID_6115 | |
| 0.02 | 0.122 | 0.042 | MAP3K5 inhibitor | 0.042 0.021 CID_6115 | CID_6115 | |
| 0.025 | 0.129 | 0.053 | EphB4 antagonist | 0.053 0.046 CID_6115 | CID_6115 | |
| 0.034 | 0.139 | 0.068 | 5 Hydroxytryptamine 5 antagonist | 0.068 0.027 CID_6115 | CID_6115 | |
| 0.014 | 0.119 | 0.034 | Estrogen-related receptor alpha antagonist | 0.034 0.021 CID_6115 | CID_6115 | |
| 0.058 | 0.165 | 0.133 | Thioredoxin inhibitor | 0.133 0.023 CID_6115 0.083 0.076 CID_14535 | CID_6115 | |
| 0.027 | 0.134 | 0.052 | Aldosterone antagonist | 0.052 0.027 CID_6115 | CID_6115 | |
| 0.015 | 0.126 | 0.036 | Thrombin receptor antagonist | 0.036 0.013 CID_6115 | CID_6115 | |
| 0.073 | 0.185 | 0.199 | Toll-Like receptor antagonist | 0.199 0.031 CID_6115 0.138 0.065 CID_14535 | CID_6115 | |
| 0.011 | 0.123 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 CID_6115 | CID_6115 | |
| 0.049 | 0.163 | 0.12 | Histamine H2 receptor antagonist | 0.12 0.021 CID_6115 | CID_6115 | |
| 0.011 | 0.125 | 0.023 | Toll-Like receptor 8 agonist | 0.023 0.009 CID_6115 | CID_6115 | |
| 0.024 | 0.138 | 0.078 | Acetylcholine M5 receptor agonist | 0.078 0.036 CID_6115 | CID_6115 | |
| 0.025 | 0.14 | 0.072 | 5 Hydroxytryptamine 2A agonist | 0.072 0.035 CID_6115 | CID_6115 | |
| 0.031 | 0.146 | 0.081 | Glutamate receptor agonist | 0.081 0.052 CID_6115 | CID_6115 | |
| 0.015 | 0.131 | 0.038 | Glutamate (mGluR group II) antagonist | 0.038 0.027 CID_6115 | CID_6115 | |
| 0.012 | 0.128 | 0.023 | ICAM 1 antagonist | 0.023 0.015 CID_6115 | CID_6115 | |
| 0.02 | 0.137 | 0.043 | Glutamate (mGluR5) agonist | 0.043 0.037 CID_6115 | CID_6115 | |
| 0.033 | 0.151 | 0.12 | Nicotinic alpha4beta2 receptor antagonist | 0.12 0.018 CID_6115 | CID_6115 | |
| 0.017 | 0.135 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.019 CID_6115 | CID_6115 | |
| 0.018 | 0.138 | 0.082 | Histamine H2 receptor agonist | 0.082 0.007 CID_6115 | CID_6115 | |
| 0.055 | 0.175 | 0.131 | GABA receptor agonist | 0.131 0.048 CID_6115 | CID_6115 | |
| 0.005 | 0.127 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 CID_6115 | CID_6115 | |
| 0.021 | 0.144 | 0.044 | Plasmepsin II inhibitor | 0.044 0.024 CID_6115 | CID_6115 | |
| 0.078 | 0.202 | 0.173 | Diuretic | 0.173 0.059 CID_6115 | CID_6115 | |
| 0.005 | 0.13 | 0.042 | Histone deacetylase 3 inhibitor | 0.042 0.011 CID_6115 | CID_6115 | |
| 0.032 | 0.157 | 0.063 | Phosphodiesterase 1B inhibitor | 0.063 0.038 CID_6115 | CID_6115 | |
| 0.08 | 0.204 | 0.31 | TRKC antagonist | 0.31 0.024 CID_6115 | CID_6115 | |
| 0.036 | 0.163 | 0.061 | Phosphodiesterase 1A inhibitor | 0.061 0.038 CID_6115 | CID_6115 | |
| 0.015 | 0.143 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.023 CID_6115 | CID_6115 | |
| 0.039 | 0.169 | 0.083 | Potassium channel (Tandem pore domain) blocker | 0.083 0.028 CID_6115 | CID_6115 | |
| 0.018 | 0.148 | 0.04 | ATR kinase inhibitor | 0.04 0.013 CID_6115 | CID_6115 | |
| 0.04 | 0.172 | 0.12 | MAP kinase kinase kinase inhibitor | 0.12 0.051 CID_6115 | CID_6115 | |
| 0.023 | 0.155 | 0.068 | Pim-2 kinase inhibitor | 0.068 0.025 CID_6115 | CID_6115 | |
| 0.056 | 0.189 | 0.1 | Thioredoxin reductase inhibitor | 0.1 0.029 CID_6115 | CID_6115 | |
| 0.022 | 0.155 | 0.086 | 5 Hydroxytryptamine 6 antagonist | 0.086 0.02 CID_6115 | CID_6115 | |
| 0.007 | 0.141 | 0.033 | Purinergic P2X agonist | 0.033 0.016 CID_6115 | CID_6115 | |
| 0.02 | 0.155 | 0.052 | Prolyl endopeptidase inhibitor | 0.052 0.034 CID_6115 | CID_6115 | |
| 0.023 | 0.159 | 0.084 | Potassium channel small-conductance Ca-activated blocker | 0.084 0.009 CID_6115 | CID_6115 | |
| 0.021 | 0.16 | 0.05 | Diacylglycerol O-acyltransferase inhibitor | 0.05 0.036 CID_6115 | CID_6115 | |
| 0.064 | 0.203 | 0.12 | Nav1.5 sodium channel blocker | 0.12 0.055 CID_6115 | CID_6115 | |
| 0.035 | 0.177 | 0.08 | Insulin growth factor antagonist | 0.08 0.067 CID_6115 | CID_6115 | |
| 0.007 | 0.149 | 0.073 | Endothelial nitric-oxide synthase inhibitor | 0.073 0.005 CID_6115 | CID_6115 | |
| 0.013 | 0.156 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 CID_6115 | CID_6115 | |
| 0.011 | 0.155 | 0.078 | Urokinase inhibitor | 0.078 0.022 CID_6115 | CID_6115 | |
| 0.031 | 0.177 | 0.087 | Acetylcholine nicotinic antagonist | 0.087 0.048 CID_6115 | CID_6115 | |
| 0.022 | 0.168 | 0.048 | Nicotinic alpha7 receptor agonist | 0.048 0.046 CID_6115 | CID_6115 | |
| 0.016 | 0.164 | 0.107 | Adenosine A1 receptor antagonist | 0.107 0.022 CID_6115 | CID_6115 | |
| 0.025 | 0.174 | 0.086 | Benzodiazepine agonist | 0.086 0.034 CID_6115 | CID_6115 | |
| 0.021 | 0.17 | 0.046 | Adenosine uptake inhibitor | 0.046 0.006 CID_6115 | CID_6115 | |
| 0.015 | 0.166 | 0.102 | Adenosine A2a receptor antagonist | 0.102 0.024 CID_6115 0.058 0.047 CID_14535 | CID_6115 | |
| 0.021 | 0.173 | 0.054 | Cyclin-dependent kinase 6 inhibitor | 0.054 0.048 CID_6115 | CID_6115 | |
| 0.009 | 0.161 | 0.035 | 5 Hydroxytryptamine 3B antagonist | 0.035 0.026 CID_6115 | CID_6115 | |
| 0.014 | 0.166 | 0.052 | Acetylcholine muscarinic agonist | 0.052 0.04 CID_6115 | CID_6115 | |
| 0.035 | 0.188 | 0.082 | Alpha 2 adrenoreceptor antagonist | 0.082 0.064 CID_6115 | CID_6115 | |
| 0.033 | 0.186 | 0.088 | Bcr-Abl kinase inhibitor | 0.088 0.054 CID_6115 | CID_6115 | |
| 0.021 | 0.181 | 0.047 | mTOR inhibitor | 0.047 0.042 CID_6115 | CID_6115 | |
| 0.063 | 0.225 | 0.111 | Antibacterial (Helicobacter pylori) | 0.111 0.097 CID_6115 | CID_6115 | |
| 0.022 | 0.184 | 0.078 | CDC7 inhibitor | 0.078 0.037 CID_6115 | CID_6115 | |
| 0.014 | 0.177 | 0.036 | Factor XIIIa inhibitor | 0.036 0.028 CID_6115 | CID_6115 | |
| 0.019 | 0.183 | 0.067 | Cyclin A1 inhibitor | 0.067 0.026 CID_6115 | CID_6115 | |
| 0.017 | 0.184 | 0.067 | Toll-Like receptor 8 antagonist | 0.067 0.026 CID_6115 | CID_6115 | |
| 0.031 | 0.202 | 0.075 | Insulin like growth factor 1 antagonist | 0.075 0.068 CID_6115 | CID_6115 | |
| 0.051 | 0.224 | 0.128 | Tyrosine-protein kinase receptor antagonist | 0.128 0.079 CID_6115 | CID_6115 | |
| 0.004 | 0.177 | 0.026 | 5 Hydroxytryptamine 1D agonist | 0.026 0.023 CID_6115 | CID_6115 | |
| 0.019 | 0.194 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.024 CID_6115 | CID_6115 | |
| 0.016 | 0.191 | 0.072 | 5 Hydroxytryptamine 4 antagonist | 0.072 0.016 CID_6115 | CID_6115 | |
| 0.014 | 0.191 | 0.033 | Complement factor 1r inhibitor | 0.033 0.008 CID_6115 | CID_6115 | |
| 0.009 | 0.19 | 0.031 | LFA antagonist | 0.031 0.014 CID_6115 | CID_6115 | |
| 0.033 | 0.215 | 0.089 | Acetylcholine agonist | 0.089 0.056 CID_6115 | CID_6115 | |
| 0.053 | 0.237 | 0.105 | Toll-Like receptor 4 antagonist | 0.105 0.063 CID_6115 | CID_6115 | |
| 0.045 | 0.23 | 0.126 | TRKA antagonist | 0.126 0.063 CID_6115 | CID_6115 | |
| 0.057 | 0.243 | 0.172 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.172 0.057 CID_6115 0.119 0.109 CID_14535 | CID_6115 | |
| 0.013 | 0.2 | 0.041 | Protein kinase (CK1) epsilon inhibitor | 0.041 0.024 CID_6115 | CID_6115 | |
| 0.018 | 0.205 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | 0.06 0.029 CID_6115 | CID_6115 | |
| 0.027 | 0.215 | 0.215 | Sodium/calcium exchanger inhibitor | 0.215 0.003 CID_6115 0.054 0.027 CID_14535 | CID_6115 | |
| 0.032 | 0.221 | 0.11 | Secretase beta inhibitor | 0.11 0.014 CID_6115 | CID_6115 | |
| 0.037 | 0.226 | 0.094 | Aurora-B kinase inhibitor | 0.094 0.09 CID_6115 | CID_6115 | |
| 0.02 | 0.21 | 0.077 | Neuronal nicotinic receptor antagonist | 0.077 0.039 CID_6115 | CID_6115 | |
| 0.014 | 0.205 | 0.096 | Adenosine A2 receptor antagonist | 0.096 0.028 CID_6115 | CID_6115 | |
| 0.012 | 0.203 | 0.057 | Adenosine A2b receptor antagonist | 0.057 0.027 CID_6115 | CID_6115 | |
| 0.009 | 0.202 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.009 CID_6115 | CID_6115 | |
| 0.06 | 0.254 | 0.157 | Cholinergic | 0.157 0.071 CID_6115 | CID_6115 | |
| 0.021 | 0.216 | 0.067 | Histamine H4 receptor antagonist | 0.067 0.014 CID_6115 | CID_6115 | |
| 0.044 | 0.241 | 0.103 | Polo-like kinase-1 inhibitor | 0.103 0.042 CID_6115 | CID_6115 | |
| 0.051 | 0.25 | 0.315 | Psychostimulant | 0.315 0.039 CID_6115 0.148 0.118 CID_14535 | CID_6115 | |
| 0.037 | 0.236 | 0.108 | Gastric antisecretory | 0.108 0.056 CID_6115 | CID_6115 | |
| 0.011 | 0.216 | 0.05 | Potassium channel KCNQ activator | 0.05 0.016 CID_6115 | CID_6115 | |
| 0.011 | 0.216 | 0.05 | Delayed rectifier potassium channel activator | 0.05 0.016 CID_6115 | CID_6115 | |
| 0.015 | 0.222 | 0.073 | Antineoplastic antibiotic | 0.073 0.062 CID_14535 | CID_14535 | |
| 0.032 | 0.24 | 0.133 | c-Src kinase inhibitor | 0.12 0.075 CID_6115 0.133 0.066 CID_14535 | CID_14535 | |
| 0.032 | 0.241 | 0.186 | Telomerase inhibitor | 0.186 0.015 CID_6115 | CID_6115 | |
| 0.03 | 0.24 | 0.1 | Granulocyte macrophage colony stimulating factor antagonist | 0.1 0.071 CID_6115 | CID_6115 | |
| 0.021 | 0.236 | 0.079 | Rho-associated kinase I inhibitor | 0.079 0.047 CID_6115 | CID_6115 | |
| 0.014 | 0.229 | 0.078 | CDK9/cyclin T1 inhibitor | 0.078 0.027 CID_6115 | CID_6115 | |
| 0.016 | 0.231 | 0.044 | Acid-sensing ion channel blocker | 0.044 0.023 CID_6115 | CID_6115 | |
| 0.004 | 0.22 | 0.019 | Histamine H4 receptor agonist | 0.019 0.012 CID_6115 | CID_6115 | |
| 0.037 | 0.254 | 0.101 | 5 Hydroxytryptamine 2B antagonist | 0.101 0.082 CID_6115 | CID_6115 | |
| 0.047 | 0.264 | 0.085 | ABCA1 expression enhancer | 0.085 0.076 CID_6115 | CID_6115 | |
| 0.075 | 0.295 | 0.141 | Antipruritic | 0.141 0.106 CID_6115 | CID_6115 | |
| 0.037 | 0.259 | 0.189 | Nitric-oxide synthase inhibitor | 0.189 0.011 CID_6115 0.09 0.077 CID_14535 | CID_6115 | |
| 0.004 | 0.227 | 0.049 | Acetylcholine M4 receptor agonist | 0.049 0.012 CID_6115 | CID_6115 | |
| 0.006 | 0.235 | 0.062 | Vascular adhesion protein 1 inhibitor | 0.062 0.009 CID_6115 | CID_6115 | |
| 0.011 | 0.244 | 0.058 | Raf kinase C inhibitor | 0.058 0.043 CID_14535 | CID_14535 | |
| 0.023 | 0.259 | 0.087 | Cyclin B3 inhibitor | 0.087 0.034 CID_6115 | CID_6115 | |
| 0.04 | 0.28 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 CID_6115 | CID_6115 | |
| 0.024 | 0.27 | 0.097 | Cyclin-dependent kinase 5 inhibitor | 0.097 0.078 CID_6115 | CID_6115 | |
| 0.039 | 0.286 | 0.088 | DNA directed RNA polymerase inhibitor | 0.088 0.072 CID_6115 | CID_6115 | |
| 0.013 | 0.262 | 0.052 | CC chemokine 2 receptor antagonist | 0.052 0.042 CID_6115 | CID_6115 | |
| 0.025 | 0.275 | 0.156 | Inducible nitric-oxide synthase inhibitor | 0.156 0.015 CID_6115 | CID_6115 | |
| 0.028 | 0.28 | 0.115 | RET inhibitor | 0.115 0.083 CID_6115 | CID_6115 | |
| 0.018 | 0.271 | 0.063 | CDK2/cyclin E2 inhibitor | 0.063 0.058 CID_6115 | CID_6115 | |
| 0.006 | 0.259 | 0.045 | Opioid delta receptor agonist | 0.045 0.016 CID_6115 | CID_6115 | |
| 0.045 | 0.303 | 0.122 | Nav1.1 sodium channel blocker | 0.122 0.047 CID_6115 | CID_6115 | |
| 0.014 | 0.273 | 0.072 | Fibroblast growth factor 3 antagonist | 0.072 0.062 CID_6115 | CID_6115 | |
| 0.007 | 0.267 | 0.068 | Glutamate (mGluR1) antagonist | 0.068 0.032 CID_6115 | CID_6115 | |
| 0.143 | 0.406 | 0.427 | MAP kinase kinase 6 inhibitor | 0.427 0.044 CID_6115 0.243 0.199 CID_14535 | CID_6115 | |
| 0.108 | 0.372 | 0.177 | Peptidyltransferase inhibitor | 0.177 0.134 CID_6115 0.169 0.149 CID_14535 | CID_6115 | |
| 0.012 | 0.283 | 0.062 | 5 Hydroxytryptamine 3 antagonist | 0.062 0.034 CID_6115 | CID_6115 | |
| 0.04 | 0.311 | 0.35 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.35 0.017 CID_6115 0.165 0.106 CID_14535 | CID_6115 | |
| 0.012 | 0.284 | 0.064 | Glutamate (mGluR1a) antagonist | 0.064 0.013 CID_6115 | CID_6115 | |
| 0.006 | 0.28 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.02 CID_6115 | CID_6115 | |
| 0.102 | 0.377 | 0.37 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.37 0.029 CID_6115 0.22 0.135 CID_14535 | CID_6115 | |
| 0.021 | 0.3 | 0.07 | Factor IXa inhibitor | 0.07 0.02 CID_6115 | CID_6115 | |
| 0.028 | 0.309 | 0.088 | I kappa B kinase 1 inhibitor | 0.088 0.03 CID_6115 | CID_6115 | |
| 0.134 | 0.414 | 0.39 | MAP kinase kinase 3 inhibitor | 0.39 0.003 CID_6115 0.252 0.03 CID_14535 | CID_6115 | |
| 0.034 | 0.315 | 0.21 | CDC-like kinase 1 inhibitor | 0.21 0.031 CID_6115 0.113 0.103 CID_14535 | CID_6115 | |
| 0.022 | 0.305 | 0.161 | Pim-1 kinase inhibitor | 0.161 0.024 CID_6115 | CID_6115 | |
| 0.037 | 0.321 | 0.181 | Src kinase inhibitor | 0.181 0.064 CID_6115 0.147 0.085 CID_14535 | CID_6115 | |
| 0.032 | 0.317 | 0.334 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.334 0.018 CID_6115 | CID_6115 | |
| 0.014 | 0.313 | 0.076 | HIV-1 reverse transcriptase inhibitor | 0.076 0.045 CID_6115 | CID_6115 | |
| 0.01 | 0.308 | 0.018 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.013 CID_6115 | CID_6115 | |
| 0.017 | 0.317 | 0.084 | TIE-2 antagonist | 0.084 0.053 CID_6115 | CID_6115 | |
| 0.031 | 0.332 | 0.107 | Sodium channel (voltage-gated) blocker | 0.107 0.101 CID_6115 | CID_6115 | |
| 0.051 | 0.353 | 0.276 | Death-associated protein kinase 3 inhibitor | 0.276 0.044 CID_6115 | CID_6115 | |
| 0.03 | 0.333 | 0.101 | Insulin receptor antagonist | 0.101 0.06 CID_6115 | CID_6115 | |
| 0.015 | 0.318 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.038 CID_6115 | CID_6115 | |
| 0.048 | 0.355 | 0.138 | CDK3/cyclin E inhibitor | 0.138 0.036 CID_6115 | CID_6115 | |
| 0.016 | 0.323 | 0.085 | TIE antagonist | 0.085 0.055 CID_6115 | CID_6115 | |
| 0.056 | 0.364 | 0.328 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.328 0.029 CID_6115 0.159 0.116 CID_14535 | CID_6115 | |
| 0.012 | 0.32 | 0.067 | Histamine agonist | 0.067 0.022 CID_6115 | CID_6115 | |
| 0.103 | 0.414 | 0.499 | ErbB-1 antagonist | 0.499 0.008 CID_6115 0.172 0.13 CID_14535 | CID_6115 | |
| 0.04 | 0.352 | 0.125 | Calcium channel N-type blocker | 0.125 0.058 CID_6115 | CID_6115 | |
| 0.043 | 0.357 | 0.246 | Protein kinase (CK1) gamma 3 inhibitor | 0.246 0.028 CID_6115 | CID_6115 | |
| 0.012 | 0.326 | 0.07 | NMDA 2B receptor antagonist | 0.07 0.025 CID_6115 | CID_6115 | |
| 0.023 | 0.34 | 0.155 | Glutamate receptor antagonist | 0.155 0.048 CID_6115 | CID_6115 | |
| 0.03 | 0.353 | 0.199 | Protein kinase (CK1) gamma 2 inhibitor | 0.199 0.032 CID_6115 | CID_6115 | |
| 0.013 | 0.337 | 0.072 | 5 Hydroxytryptamine 3A antagonist | 0.072 0.039 CID_6115 | CID_6115 | |
| 0.016 | 0.342 | 0.048 | Dipeptidyl peptidase inhibitor | 0.048 0.046 CID_6115 | CID_6115 | |
| 0.019 | 0.345 | 0.075 | Epidermal growth factor antagonist | 0.075 0.074 CID_6115 | CID_6115 | |
| 0.03 | 0.357 | 0.114 | Epidermal growth factor receptor kinase inhibitor | 0.114 0.08 CID_6115 | CID_6115 | |
| 0.055 | 0.388 | 0.158 | Hepatoprotectant | 0.158 0.101 CID_14535 | CID_14535 | |
| 0.042 | 0.375 | 0.41 | Toll-Like receptor 3 antagonist | 0.41 0.002 CID_6115 0.123 0.027 CID_14535 | CID_6115 | |
| 0.029 | 0.365 | 0.111 | Sodium channel blocker | 0.111 0.097 CID_6115 | CID_6115 | |
| 0.073 | 0.411 | 0.205 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.205 0.069 CID_6115 | CID_6115 | |
| 0.026 | 0.367 | 0.064 | Trypsin inhibitor | 0.064 0.041 CID_6115 | CID_6115 | |
| 0.015 | 0.358 | 0.105 | Butyrylcholinesterase inhibitor | 0.105 0.058 CID_6115 | CID_6115 | |
| 0.027 | 0.376 | 0.265 | Clk dual-specificity kinase inhibitor | 0.265 0.049 CID_6115 | CID_6115 | |
| 0.034 | 0.385 | 0.079 | Prolactin release inhibitor | 0.079 0.011 CID_6115 | CID_6115 | |
| 0.021 | 0.372 | 0.219 | Lck kinase inhibitor | 0.219 0.033 CID_6115 0.125 0.081 CID_14535 | CID_6115 | |
| 0.036 | 0.388 | 0.239 | Angiogenesis stimulant | 0.239 0.075 CID_6115 0.144 0.127 CID_14535 | CID_6115 | |
| 0.02 | 0.373 | 0.115 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.115 0.073 CID_6115 | CID_6115 | |
| 0.019 | 0.374 | 0.114 | Abl kinase inhibitor | 0.114 0.073 CID_6115 | CID_6115 | |
| 0.05 | 0.406 | 0.282 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.282 0.048 CID_6115 | CID_6115 | |
| 0.012 | 0.371 | 0.133 | Check point kinase 2 inhibitor | 0.133 0.04 CID_6115 | CID_6115 | |
| 0.029 | 0.394 | 0.264 | Protein kinase (CK1) gamma 1 inhibitor | 0.264 0.026 CID_6115 | CID_6115 | |
| 0.128 | 0.493 | 0.2 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.2 0.166 CID_6115 | CID_6115 | |
| 0.021 | 0.398 | 0.13 | Vascular endothelial growth factor 3 antagonist | 0.13 0.085 CID_6115 | CID_6115 | |
| 0.058 | 0.438 | 0.389 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.389 0.017 CID_6115 | CID_6115 | |
| 0.026 | 0.407 | 0.375 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.375 0.022 CID_6115 0.121 0.115 CID_14535 | CID_6115 | |
| 0.109 | 0.505 | 0.258 | Antiinflammatory | 0.258 0.257 CID_14535 | CID_14535 | |
| 0.017 | 0.413 | 0.165 | Protein-tyrosine kinase Lyn inhibitor | 0.165 0.059 CID_6115 | CID_6115 | |
| 0.005 | 0.402 | 0.045 | Factor VII inhibitor | 0.045 0.013 CID_6115 | CID_6115 | |
| 0.018 | 0.417 | 0.255 | Protein kinase (CK1) gamma inhibitor | 0.255 0.028 CID_6115 | CID_6115 | |
| 0.016 | 0.417 | 0.078 | CDK/cyclin complex inhibitor | 0.078 0.071 CID_6115 | CID_6115 | |
| 0.014 | 0.419 | 0.156 | Protein kinase (CK1) inhibitor | 0.156 0.063 CID_6115 | CID_6115 | |
| 0.026 | 0.431 | 0.095 | Gonadotropin-releasing hormone receptor agonist | 0.095 0.011 CID_6115 0.057 0.046 CID_14535 | CID_6115 | |
| 0.019 | 0.439 | 0.245 | CDC-like kinase 4 inhibitor | 0.245 0.048 CID_6115 | CID_6115 | |
| 0.021 | 0.444 | 0.281 | Protein kinase C nu inhibitor | 0.281 0.028 CID_6115 | CID_6115 | |
| 0.017 | 0.449 | 0.223 | CDC-like kinase 2 inhibitor | 0.223 0.055 CID_6115 | CID_6115 | |
| 0.016 | 0.458 | 0.148 | Vascular endothelial growth factor 1 antagonist | 0.148 0.042 CID_6115 | CID_6115 | |
| 0.011 | 0.454 | 0.07 | Protein kinase C alpha inhibitor | 0.068 0.046 CID_6115 0.07 0.044 CID_14535 | CID_14535 | |
| 0.039 | 0.492 | 0.436 | Interleukin 6 antagonist | 0.436 0.005 CID_6115 0.2 0.04 CID_14535 | CID_6115 | |
| 0.013 | 0.472 | 0.092 | MAP-kinase-activated kinase 2 inhibitor | 0.092 0.034 CID_6115 | CID_6115 | |
| 0.025 | 0.489 | 0.268 | Anticonvulsant | 0.268 0.05 CID_6115 | CID_6115 | |
| 0.017 | 0.488 | 0.103 | MAP-kinase-activated kinase inhibitor | 0.103 0.037 CID_6115 | CID_6115 | |
| 0.009 | 0.486 | 0.098 | Platelet activating factor beta antagonist | 0.098 0.064 CID_6115 | CID_6115 | |
| 0.011 | 0.515 | 0.079 | Phosphodiesterase 7A inhibitor | 0.079 0.007 CID_6115 | CID_6115 | |
| 0.013 | 0.519 | 0.125 | Polo-like kinase-4 inhibitor | 0.125 0.052 CID_6115 | CID_6115 | |
| 0.024 | 0.537 | 0.373 | Antimitotic | 0.373 0.028 CID_14535 | CID_14535 | |
| 0.026 | 0.543 | 0.192 | Phosphodiesterase 7B inhibitor | 0.192 0.011 CID_6115 | CID_6115 | |
| 0.029 | 0.554 | 0.227 | Polo-like kinase-3 inhibitor | 0.227 0.033 CID_6115 | CID_6115 | |
| 0.013 | 0.544 | 0.246 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.246 0.033 CID_6115 | CID_6115 | |
| 0.008 | 0.554 | 0.102 | CDK2/cyclin A inhibitor | 0.102 0.056 CID_6115 | CID_6115 | |
| 0.009 | 0.568 | 0.15 | MAP kinase 8 inhibitor | 0.15 0.03 CID_6115 0.106 0.054 CID_14535 | CID_6115 | |
| 0.017 | 0.576 | 0.149 | MAP kinase 13 inhibitor | 0.131 0.047 CID_6115 0.149 0.036 CID_14535 | CID_14535 | |
| 0.069 | 0.637 | 0.212 | MAP kinase kinase 5 inhibitor | 0.212 0.021 CID_6115 | CID_6115 | |
| 0.011 | 0.585 | 0.162 | MAP kinase 9 inhibitor | 0.162 0.033 CID_6115 | CID_6115 | |
| 0.01 | 0.588 | 0.067 | Thrombin inhibitor | 0.067 0.059 CID_6115 | CID_6115 | |
| 0.023 | 0.603 | 0.081 | MAP kinase 7 inhibitor | 0.081 0.043 CID_6115 | CID_6115 | |
| 0.029 | 0.617 | 0.102 | T cell inhibitor | 0.102 0.023 CID_6115 | CID_6115 | |
| 0.005 | 0.597 | 0.1 | Phosphodiesterase VII inhibitor | 0.1 0.013 CID_6115 | CID_6115 | |
| 0.006 | 0.603 | 0.074 | Protein kinase A inhibitor | 0.074 0.066 CID_6115 | CID_6115 | |
| 0.029 | 0.626 | 0.224 | Angiogenesis inhibitor | 0.194 0.177 CID_6115 0.224 0.144 CID_14535 | CID_14535 | |
| 0.014 | 0.61 | 0.13 | Cyclin-dependent kinase 7 inhibitor | 0.13 0.076 CID_6115 | CID_6115 | |
| 0.008 | 0.608 | 0.079 | Protein kinase B beta inhibitor | 0.079 0.044 CID_6115 | CID_6115 | |
| 0.009 | 0.612 | 0.116 | TRKB antagonist | 0.116 0.078 CID_6115 | CID_6115 | |
| 0.034 | 0.641 | 0.09 | Transforming growth factor beta 3 antagonist | 0.09 0.038 CID_6115 | CID_6115 | |
| 0.009 | 0.617 | 0.08 | Platelet growth factor antagonist | 0.08 0.057 CID_6115 | CID_6115 | |
| 0.005 | 0.635 | 0.084 | Fibroblast growth factor 1 antagonist | 0.084 0.071 CID_6115 | CID_6115 | |
| 0.009 | 0.64 | 0.095 | MAP kinase 11 inhibitor | 0.095 0.039 CID_6115 | CID_6115 | |
| 0.005 | 0.651 | 0.091 | Factor VIIa inhibitor | 0.091 0.012 CID_6115 | CID_6115 | |
| 0.038 | 0.721 | 0.166 | Growth factor agonist | 0.166 0.109 CID_6115 | CID_6115 | |
| 0.005 | 0.693 | 0.068 | Protein kinase B gamma inhibitor | 0.068 0.06 CID_6115 | CID_6115 | |
| 0.014 | 0.715 | 0.18 | Vasodilator | 0.18 0.122 CID_14535 | CID_14535 | |
| 0.008 | 0.791 | 0.082 | Potassium channel (Ca-activated) blocker | 0.082 0.017 CID_6115 | CID_6115 | |
| 0.011 | 0.816 | 0.071 | Phosphodiesterase VIII inhibitor | 0.071 0.051 CID_6115 | CID_6115 | |
| 0.011 | 0.888 | 0.217 | Immunomodulator | 0.217 0.144 CID_6115 | CID_6115 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |